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Abstract
The use of small ﬁelds has substantially increased in radiotherapy during
recent years mainly due to expansion in the use of modulated techniques
which are also used at some institutions for Stereotactic Body Radiotherapy
(SBRT). The use of modulated techniques in lung SBRT is controversial
due to the interplay eﬀect. At the same time, small-volume dosemeters
have appeared on the market in an attempt to try to cover new dosimetry
necessities.
This PhD deals with diﬀerent features related to small-ﬁeld dosimetry.
It ﬁrst analyzes the inﬂuence of diﬀerences between ionization chambers of
the same type on dosimetry factors determining 0.5% as the upper limit on
the possible inﬂuence. Correction factors for PTW-31016 are also proposed
and the eﬀect of a particular chamber of this model has been found to be up
to 2.8% for 0.5 cm square. These correction factors have been determined
by Monte Carlo calculations and have been validated with measurements on
ﬂattened and unﬂattened beams by analyzing the main sources of inﬂuence.
The last chapter is devoted to SBRT, and suggests a fast and accurate plan
set-up together with PUMA, a method to evaluate the interplay eﬀect in
lung SBRT.
Keywords: Correction factors, small ﬁeld dosimetry, kQ,Qo , k
fclin,fmsr
Qclin,Qmsr
,
SABR, SBRT, Monte Carlo simulation, ionization chamber
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Preface
Radiotherapy has evolved signiﬁcantly in recent years. Probably the most
relevant change, from a clinical point of view, is the implementation of ex-
tracranial radiosurgery called SBRT (Stereotactic Body Radiotherapy) or
SABR (Stereotactic Ablative Radiotherapy). The appearance in 2010 of a
task group from the American Association of Physics in Medicine (AAPM)
and more than 5000 references related to this technique over the last ﬁve
years shows its importance. At the beginning of 2000, prior to the expan-
sion of SBRT, improvements in the precision of linear accelerators combined
with the increase in calculation speed of computer systems has led to the
emergence of Intensity Modulated Radiotherapy (IMRT) and later, in 2007,
Volumetric Modulated Arc Therapy (VMAT), where intensity modulation
is performed on an arc. Both techniques imply the use of small treatment
ﬁelds deﬁned for stereotactic irradiation or as segments in IMRT techniques.
Due to the great increase in their use, a new approach to reference dosimetry
of small ﬁelds was proposed in 2008 since existing codes of practice were not
designed to successfully cover small-ﬁeld dosimetry. The most notable point
of the new approach is the deﬁnition of a new correction factor that must be
applied to the diﬀerent detectors when small-ﬁeld determinations are per-
formed. More than 400 references have appeared during the last ﬁve years
referring to small-ﬁeld dosimetry, and these can be divided between charac-
terization of detectors in small-ﬁeld dosimetry on a new machine and/or the
proposal of correction factors for some detectors.
This thesis consists on the study of three diﬀerent topics which aim to
address some of the present challenges in radiotherapy. They can be di-
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vided between the eﬀect of detector geometric tolerances within an ioniza-
tion chamber on basic dosimetric parameters, determination of correction
factors for a particular detector in a new linear accelerator and the inﬂuence
of geometric tolerances on these correction factors. Finally, the development
of a method to analyze the eﬀect of VMAT on lung SABR treatments is
proposed.
The text is structured with a general introduction in Chapter 1, the
description of the materials and the details of Monte Carlo simulations are
given in Chapter 2. Chapter 3 describes the methodology used for the study
of the three topics and Chapters 4 to 6 present the results and discussion of
each of the topics. Finally, conclusions are summarized in Chapter 7.
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Chapter 1
Introduction
Cancer is a general term used to refer to a condition where the body's cells
begin to grow and reproduce in an uncontrollable way. These cells can then
invade and destroy healthy tissue, including organs. More than one in three
people will develop some form of cancer during their lifetime and, along with
cardiovascular disease, are the most common cause of death. The treatment
of cancer has become one of the most prominent world health issues due to
both its prevalence and mortality. More than 50% of cancer patients will
receive radiotherapy at some stage during the course of their illness [1, 2]
and this may be combined with surgery and/or chemotherapy.
1.1 Basic radiotherapy concepts
Radiotherapy aims to eliminate or mitigate disease by delivering high doses
of radiation to diseased tissue whilst minimising the dose to healthy tis-
sue. The equilibrium between these variables has led to the development of
new radiotherapy techniques. Developments in the diagnosis detection pro-
cess including computed tomography (CT), positron emission tomography
(PET) and magnetic resonance (MR) imaging provide the necessary three-
1
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dimensional (3D) anatomical information prior to treatment. This process
allows better delineation of tumoral zones and a reduction of irradiation vol-
umes. Diﬀerent types of radiation (photons, electrons, protons and ions) and
a wide range of energies can be used in radiotherapy. Our work is centred
on the use of external megavoltage photon beams generated on a electron
linear accelerator (LINAC).
Linear accelerators producing wide ﬂattened photon beams (FF) have
been used in clinical practice for more than 50 years. Photon beams are
created by the impact of a narrow monoenergetic electron beam on a target.
The impact of this electron beam produces a wide photon beam after passing
through the target, which has a wide spectrum of energies due to the diﬀerent
interactions produced within the target and geometrically it has a higher
ﬂuence in the centre of the beam.( Figure 1.1).
Figure 1.1: Basic linear accelerator scheme
Current conformed radiotherapy is based on the use of photon beams
that are shaped by using two pairs of movable jaws situated perpendicularly
allowing conformation of the radiation with asymmetric rectangles and the
use of a multileaf collimator (MLC). The MLC is a device made up of in-
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dividual "leaves" that can be positioned independently in the beam path
in order to block it and create beam apertures with more irregular shapes
allowing for a better conformation of the volume. (Figure 1.2)
Figure 1.2: Multileaf collimator (MLC) from a Varian Medical Systems elec-
tron linear accelerator
In general, an homogeneous dose distribution on the planning target
volume (PTV) is desired and consequently ﬂattened (homogeneous) beams
are an advantage. To create ﬂattened beams, LINACs have a conical piece
made of Cu, tungsten or stainless steel, called ﬂattening ﬁlter, which when
inserted in the path of the photon beam, reduces the photon ﬂuence in the
central part. The ﬂattening ﬁlter is speciﬁc for each energy and has other
important eﬀects on the photon beam. It absorbs some of the photons with
lower energy, which is a desired eﬀect since photons with lower energies
will tend to deposit their energy on the skin of the patient and, in general,
photon beams are used to deliver doses to volumes that are within the body.
However, ﬂattening of the beam is achieved by absorbing part of the radiation
in the central part and implies a reduction in the dose rate for the ﬂattened
beam compared with the unﬂattened beam.
To measure the amount of radiation delivered by the linear accelerator,
a set of ionization chambers, called monitor chambers, are situated after
the ﬂattening ﬁlter. The chambers monitor the dose rate that the system
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delivers. In addition, these ionization chambers, strategically designed, also
control other parameters of the beam. The Monitor Unit (MU) is deﬁned
as an arbitrary unit directly related with readings of the monitor chambers
to measure the LINAC output. The equivalence between the MU and the
dose delivered at a certain point will depend on each institution. A common
equivalence is 100 MU corresponds to 1 Gy (see section 1.2.1) for a reference
depth and ﬁeld size under isocentric conditions with a ﬁxed source-detector-
distance (SDD) or with a ﬁxed source-surface-distance (SSD). The most
common photon energies used from a LINAC in radiotherapy range from
6 MV to 18 MV. For this range, the absorbed dose in water for a beam
perpendicular to the surface follows a distribution in depth as presented in
Figure 1.3.
Figure 1.3: Percentage depth-dose proﬁles (PDD) for several photon energies
for a square ﬁeld of 10 cm side length
It can be observed that the maximum absorbed dose is situated at a
certain depth which ranges from 1.2 cm to 4 cm approximately. The max-
imum absorbed depth dose not only depends on the energy, but also on
the ﬁeld size. To achieve an appropriate dose distribution in the tumoral
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volume while preserving the surrounding tissues, a combination of beams
with diﬀerent orientations and weights focused on the volume are used. This
combination of orientations can also be created by using arcs centred on the
tumour, which is known as arc-therapy, where one or more arcs are used.
It is also possible to combine static beams and arcs in the same treatment
plan. The appropriate combination of beam orientations and shapes makes
it possible to achieve high dose to the target volume, whilst minimizing the
doses to surrounding healthy tissue.
A reduction in computing time has enabled the development of new ra-
diotherapy techniques. An advance in traditional techniques was the intro-
duction of dynamic arcs, which consist of the use of one or several arcs,
where each leaf of the MLC is adapted in each projection to maintain a ﬁxed
distance, selected by the user, to the volume. The following step is what is
known as intensity modulated radiotherapy (IMRT). IMRT consists of one
or several static orientations of the beam where photon ﬂuence varies inside
each treatment beam. Variations in the ﬂuence are produced by changing
the position of the MLC during beam delivery (sliding window) or by the ir-
radiation of multiple conformations of the MLC on a ﬁxed orientation (Step
and shoot). Some years later, modulation of the photon ﬂuence in an arc
was introduced, with some extra degrees of freedom such as variable dose
rate and arc rotation speed, known as Volumetric Modulated Arc Therapy
(VMAT). The use of modulated techniques creates dose distributions with
steeper dose gradients and a more pronounced concave and irregular confor-
mation than with conformal techniques. Consequently, better preservation
of healthy tissue/organs can be achieved with these improvements.
CHAPTER 1. INTRODUCTION 6
1.2 Basic dosimetry concepts
1.2.1 Absorbed dose deﬁnition
In 1950 the International Commission on Radiation Units and Measurements
(ICRU) formalized the deﬁnition of absorbed dose (D ) in terms of the
quantity of the energy per unit mass of irradiated material at the point
of interest. Absorbed dose is deﬁned for all types of ionizing radiation,
including charged and uncharged particles, as the mean energy imparted per
unit mass, where dε¯ is the mean energy imparted to the inﬁnitessimal mass
dm.
D =
dε¯
dm
(1.1)
In the International System of Units the unit for absorbed dose is the
Gray (Gy) deﬁned as:
1Gy = 1 J /1 kg
1.2.2 Relative dose-distribution parameters
Tissue phantom ratio (TPR) is deﬁned as the quotient between the absorbed
dose (or absorbed dose rate) in a phantom and the dose at the same point
at a ﬁxed reference depth. When the reference depth corresponds to the
maximum absorbed dose depth, the ratio is named the Tissue Maximum
Ratio (TMR) (equation 1.2).
TMR(z, fclin) =
D(z, fclin)
D(zmax, fclin)
(1.2)
Where z and zmax represent the depth and the depth at maximum dose
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and fclin is the clinical ﬁeld size.
High energy photon beams are normally characterized by their Beam
quality Q. Beam quality is deﬁned as the TPR20,10 for a ﬁeld size of 10 cm
x 10 cm where the subindexes 20 and 10 signify depths at 20 cm and 10
cm. Q is generally determined in isocentric conditions that correspond to
a source-detector distance (SDD) of 100 cm for common linear accelerators
used in external radiotherapy.
Field Output Factor (FOF) is deﬁned as the ratio between the absorbed
dose to water in reference conditions and at any other ﬁeld size, at a reference
point in a phantom.
Percentage Depth Dose distribution (PDD) (equation 1.3) represents the
relative absorbed dose deposited by a radiation beam into a medium as it
varies with depth along the axis of the beam. The dose values are normalized
at the maximum dose, yielding a plot in terms of percentage of the maximum
dose. Dose measurements are generally made in water. For points outside
the central axis, the Oﬀ Axis Ratio (OAR) (equation 1.4) is deﬁned as the
ratio of the dose at a point away from the central axis of the beam to the
dose at the central axis point situated at the same depth.
PDD(z, fclin, F ) =
D(z, fclin, F )
D(zmax, fclin, F )
× 100 (1.3)
OAR(r, z, fclin) =
D(0, z, fclin)
D(r, z, fclin)
(1.4)
Where z and zmax represent the depth and the depth at maximum dose,
fclin is the clinical ﬁeld size, r is the distance from the central axis and F is
the source-to-surface distance.
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1.2.3 Dosemeters
Before introduction of the formalism for absorbed dose determination in
reference conditions, an overview of the dosemeters used is included.
The possible eﬀects produced by the interaction of radiation with matter
are varied and include changes in temperature, luminescence, chemical pro-
perties etc. A dosemeter is considered to be any device capable of providing
a reading that is a measure of the dose in its sensitive volume, and with
appropiate calibration to provide the desired quantity [3]. These changes
need to meet a set of requirements such as repeatability, reproducibility,
accuracy and sensitivity. In general, the dosemeter can present dependence
on energy, dose rate, pressure, temperature, shape or accumulated dose.
These and other characteristics must be determined before their use. Apart
from physical detection principles, dosemeters can also be classiﬁed as active
or passive depending on whether they can yield real time measurements or
not.
1.2.3.1 Ionization chamber
The most common type of detector used in clinical practice in the deter-
mination of photon absorbed dose is the Ionization Chamber. Ionization
chamber is an active detector which collects all the charges created by direct
ionization within the gas or liquid through the application of an electric ﬁeld.
It only uses the discrete charges created by each interaction between the in-
cident radiation and the medium. The charges are created by the ionization
of air or liquid molecules present in the cavity by the electrons produced by
the photoelectric eﬀect, Compton scattering or pair production on the wall
chamber or on the medium surrounding it.
All ionization chambers used and studied in this thesis are cylindrical.
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Cylindrical chambers are composed of a cavity (sensitive zone) and a stem.
The cavity, in general air ﬁlled, is deﬁned by three electrodes, the polarization
electrode or external electrode, connected directly to the polarization voltage.
The collection electrode is connected to an electrometer which has a high
impedance and collects the charge or current from the air cavity. Finally,
the guard electrode, connected directly to the mass, deﬁnes the volume cavity
and prevents the collection of leakage currents. The design of an ionization
chamber is a compromise between having a cavity volume large enough to
collect an appreciable amount of charge and small enough to assign a speciﬁc
measurement to a point and to prevent important perturbations to the beam
ﬂuence.
Figure 1.4 shows a schematic diagram of a generic cylindrical ionization
chamber of the Farmer type.
Figure 1.4: Scheme of a cylindrical ionization Farmer chamber
1.2.3.2 Diode
A diode is an active dosemeter based on the eﬀects that ionizing radiation
produces on a semiconductor. Excited electrons are transferred from the
valence band to the conduction band of the crystal, generating electron-hole
pairs. The electrons and holes generated drift in opposite directions due
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to the intrinsic electric ﬁeld of the diode, and the charges can be collected.
Commercial diodes are made of silicon doped with phosphorus (n-types) or
boron (p-types). Their higher density in comparison with water shows a
diﬀerent response depending on the energy spectra which should be taken
into account. Diodes have been traditionally used for relative dosimetric
purposes, mainly due to their high sensitivity within a small volume which
confers good spatial resolution. However, they can present a directional
eﬀect and are also inﬂuenced by accumulated doses which must be regularly
monitored. An additional advantage is the fact they do not need to be
connected to a high voltage supply.
1.2.3.3 Radiochromic ﬁlm
Radiochromic or Gafchromic ﬁlm is a translucent ﬁlm that turns blue due
to a polymerization process when irradiated by ionizing radiation. These
changes are stable for temperatures below 60 °C. They can be scanned with-
out any chemical process. As traditional ﬁlm dosimetry, a calibration curve
is needed since the changes in optical density are not linear with dose. The
similar electron density to water make it a promising detector. Extended in-
formation about this passive dosemeter can be found in TG-55 from AAPM
[4].
1.2.3.4 Thermoluminescent detector (TLD)
Thermoluminescent dosimetry is based on the capacity of some imperfect
crystals to re-emit stored energy deposited by ionizing radiation in the form
of light when heated. The emitted light is correlated with the absorbed
dose. Even though they are not very common in clinical practice, thermo-
luminescent dosemeters (TLDs) are passive dosemeters that present several
CHAPTER 1. INTRODUCTION 11
advantages such as small size, low ﬂuence perturbation in MV beams and
no directional dependence. In addition, some TLDs, such as LiF, have a
relatively low eﬀective atomic number and thus a good energy response.
1.2.4 Formalism for absorbed dose determination in refer-
ence conditions
In this thesis will be used the formalism and recommendations for absorbed
dose determination in reference conditions described in the International
Atomic Energy Agency (IAEA) Technical Reports Series (TRS) 398 [5]. A
cylindrical ionization chamber is recommended for the determination of ab-
sorbed dose to water in high energy photon beams. The absorbed dose to
water at the reference depth zref in water, in a photon beam quality Q0 and
in the absence of the chamber is given by:
Dw,Qo = MQ0 ·ND,w,Qo , (1.5)
where MQ0 is the chamber reading in the reference conditions used in
the standards laboratory and ND,w,Qo is the calibration factor in terms of
absorbed dose to water at a reference quality Qo for the speciﬁc ionization
chamber (or dosemeter in general) obtained from a standard laboratory when
it is centred at zref .
Quantities of inﬂuence such as pressure, temperature, electrometer cali-
bration, polarity eﬀect and ion recombination must be considered by apply-
ing necessary factors ki to appropriately correct the readingMQ to take into
account the diﬀerences between ﬁnal user and reference conditions in the
standard laboratory. When the chamber (dosemeter in general) is used on
a diﬀerent beam quality rather than the reference quality Qo it is necessary
to introduce a chamber speciﬁc factor, kQ,Qo , which takes into account the
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diﬀerence between the reference beam quality Qo (used in the calibration
laboratory) and the actual user quality Q. A 60Co photon beam is often
used as a reference quality (Qo), in this case kQ,Qoand ND,w,Qo are denoted
as kQ and ND,w respectively.
The common expression to obtain the absorbed dose to water in a beam
quality Q diﬀerent from the calibration quality Qo, is given by equation 1.6,
where MQ has been corrected for the quantities of inﬂuence other than the
beam quality.
Dw,Q = MQ ·ND,w,Qo · kQ,Qo (1.6)
kQ,Qo can be obtained as:
kQ,Qo =
ND,w,Q
ND,w,Qo
=
Dw,Q/MQ
Dw,Qo/MQo
(1.7)
Ideally this correction factor should be determined for each ionization
chamber and beam quality used. However, in general, not all standard labo-
ratories have beams with the same beam quality as the user [5].
According to Bragg-Gray theory, the absorbed dose in a medium (water
in our case) Dw, is related to the mean absorbed dose in the air cavity
of the ionization chamber Dair, through a factor identiﬁed as the ratio of
mass(collision) stopping power ratios water/air sw,air.
Dw = Dair · sw,air (1.8)
For an ideal detector that does not perturb electron ﬂuence, these factors
would be identiﬁed as the Spencer-Attix stopping power ratios and could
be analytically determined with a set of approximations [6, 7]. As there
are no ideal detectors in the real world, a set of correction factors, pQ, are
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introduced.
kQ,Qovalues can also be obtained by the user by applying the following
relation, derived from Bragg-Gray theory [8].
kQ,Qo =
(sw,air)Q
(sw,air)Qo
· (W air)Q
(Wair)Qo
pQ
pQo
(1.9)
Where:
(sw,air)Q is the Spencer Attix water/material stopping power ratio for
the beam quality Q.
(Wair)Q is the mean energy expended in air per ion pair formed for the
beam quality Q.
pQ is the overall perturbation correction factor which includes all de-
partures from the ideal Bragg-Gray condition when a ionization chamber is
used.
Traditionally, the overall perturbation factor has been divided on the
assumption that each separate perturbation factor is small and independent
[9]. Several publications have appeared over the last 30 years evaluating
the use of the initial analytical expressions for these perturbation factors
(cited separately below). Perturbation factors pQ are generally deﬁned as
a product of independent corrections that take into account the diﬀerent
eﬀects (equation 1.10). Several analytical expressions were proposed in the
past for these perturbation factors.
pQ = pcav · pwall · pdis · pcel (1.10)
The cavity perturbation factor (pcav) corrects the eﬀects that the air
cavity produces, mainly the in-scattering, which modiﬁes the electron ﬂuence
that would be in the medium in the absence of the cavity. It is considered to
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be unity for cylindrical ionization chambers at a depth of 5 g/cm2 in water
for photon beams with an uncertainty lower than 0.1% [5].
The wall perturbation factor (pwall) takes into account the diﬀerences in
radiation response between the chamber wall material and the medium. The
initial analytical expression was formulated by Almond and Svensson in 1977
[10] and modiﬁed by Gillin et al in 1985 [11] and Hanson and Dominguez-
Tinoco in 1985 [12].
The displacement perturbation factor (pdis) depends on the inner radius
of the cavity and corrects the eﬀect of replacing the volume of the medium
(water) with the detector cavity when the reference point of the chamber is
considered to be at the centre of the chamber. An analytical expression was
suggested by Johansson et al in 1978 [13].
The central electrode perturbation factor (pcel) corrects the eﬀect created
by the presence of a central electrode in the ionization chambers. It was
experimentally investigated by Kristensen 1983 [14], Mattsson 1984 [15] and
Andreo et al 1992 [8], Nyström and Karlsson 1993 [16], Leither et al 1994
[17], Kosuen et al 1994 [18] and Palm and Mattsson 1999 [9]. It was also
studied by Monte Carlo (MC) methods, Nath and Schulz 1981 [19], Smyth
and McEwan 1984 [20], Rogers et al 1985 [21] and Ma and Nahum 1993 [22].
It is important to notice that all described factors are energy dependent
and pQ also depends on each particular chamber.
In 2004 J Sempau et al [23], proposed the introduction of fc,Q as a propor-
tionality factor relating the absorbed dose in water with the mean absorbed
dose in the detector air cavity.
Dw = D¯air · fc,Q (1.11)
Consequently, kQ,Qocan be evaluated as the ratios of the fc,Q for two
CHAPTER 1. INTRODUCTION 15
diﬀerent qualities. It is important to notice that in spite of the analogy
between expressions 1.8 and 1.11, the fc,Q factor is considered to be the
proportionality between the doses in the air cavity and in water without any
approximation. fc,Q can be obtained using MC simulations for each type of
ionization chamber by taking into consideration the real eﬀect of the detector
in water or in any other medium.
1.2.5 Small ﬁeld deﬁnition
Although there is no consensus about small ﬁeld deﬁnition, it is accepted
that ﬁelds smaller than 3 cm x 3 cm present a set of dosimetric properties
that must be speciﬁcally considered [24]. These properties are the loss of
lateral charged particle equilibrium (CPE) and possible partial occlusion of
the primary source of radiation. The ﬁeld size at which these become signif-
icant depends on beam energy, focal spot size, and jaw design. Appropriate
characterization of the beam and correct modelling of the planning system
has a major eﬀect on small ﬁelds, and the nature of the detector, geometry
and size must be considered for these ﬁeld sizes [24].
Lateral electron equilibrium (LEE) is compromised when x-ray energy is
so high or the beam radius is so small that the latter becomes comparable to
the maximum electron range [25]. This has eﬀects on the beam proﬁles and
absorbed dose on the central axis and was one of the reasons why mainly
4 MV or 6 MV beams were originally used for small ﬁelds in clinical practice
[26]. In 1990 Bjarngard et al [27] showed how the doses on the central axis of
6 MV small photon ﬁelds are aﬀected by the incomplete lateral electron equi-
librium. They used MC simulations and pointed out that the ratio between
absorbed dose and kerma characterizes the degree of electron equilibrium.
LEE depends on the energy of the beam and on the density of the medium
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(electronic density).
Partial occlusion refers to the geometrical issue presented when a ﬁnite
source collimated below a certain ﬁeld size will not be completely viewed
from points on the central axis at a certain distance from the source. This
phenomenon will have an inﬂuence on the output factor determined for that
ﬁeld size. At the same time, beam penumbras will also be aﬀected.
1.2.6 Formalism for small-ﬁeld dosimetry
In 2008 a new formalism [28] was deﬁned as an extension of the existing codes
of practice for small-ﬁeld dosimetry due to the expansion of new treatment
units and techniques which lead to situations where codes based on the
conversion from ionization to absorbed dose in ionization chambers, were
not accurate [29, 30]. The new formalism introduces a new correction factor
( kfmsr,frefQmsr,Qref ). The absorbed dose to water, D
fmsr
w,Qmsr
, at the reference depth
in water, in a beam quality Qmsr and reference machine ﬁeld fmsr and in
absence of the chamber is given by
Dfmsrw,Qmsr = M
fmsr
Qmsr
·ND,w,Qo · kQ,Qo · kfmsr,frefQmsr,Qref (1.12)
Where, fref , fmsr, refer to the conventional reference ﬁeld and the ma-
chine speciﬁc reference ﬁeld size. MfmsrQmsr are the output readings corrected for
quantities of inﬂuence (pressure, temperature, polarity and saturation) and
k
fmsr,fref
Qmsr,Qref
is the corresponding correction factor. For machines where the re-
ference ﬁeld can be established as a conventional machine ﬁeld (fmsr = fref ),
the absorbed dose to water Dfclinw,Qclin , at the reference depth in water for a
ﬁeld size fclin, is given by
Dfclinw,Qclin = M
fclin
Qclin
·ND,w,Qo · kQ,Qo · kfclin,fmsrQclin,Qmsr (1.13)
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In practice, kfclin,fmsrQclin,Qmsr can be obtained by comparing two ﬁelds with a
primary standard or by using alanine or radiochromic ﬁlm as a reference
detector [28]. Alternatively, it can be calculated by Monte Carlo (MC) si-
mulations.
With the new formalism, the absorbed dose in water at the reference
point for a ﬁeld size fclin in the absence of the chamber is given by:
Dfclinw,Qclin = D
fmsr
w,Qmsr
·Ωfclin,fmsrQclin,Qmsr (1.14)
Where Ωfclin,fmsrQclin,Qmsr represents the FOF (see section 1.2.2). Combining
the previous equations (1.12, 1.14) it can be deduced that:
Ωfclin,fmsrQclin,Qmsr =
MfclinQclin
MfmsrQmsr
·
[
Dfclinw,Qclin/M
fclin
Qclin
Dfmsrw,Qmsr/M
fmsr
Qmsr
]
=
MfclinQclin
MfmsrQmsr
· kfclin,fmsrQclin,Qmsr (1.15)
Deﬁning the output ratios (ORfclinfref ) as the ratios of the corrected readings
(1.16), it can be observed that kfclin,fmsrQclin,Qmsr is a factor which corrects the
output ratios of ionisation chambers to ﬁeld output factors (FOF).
ORfclinfref = M
fclin
Qclin
/MfmsrQmsr (1.16)
1.2.7 Monte Carlo simulation
The Monte Carlo (MC) method is a statistical method of approximating
the solution of complex physical or mathematical systems based on repeated
random sampling to obtain numerical results.
In MC simulation of radiation transport, the history (track) of a particle
is viewed as a random sequence of free ﬂights that end with an interaction
event where the particle changes its direction of movement, loses energy and,
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occasionally, produces secondary particles [31]. The Monte Carlo simulation
of a given experimental arrangement (e.g., an electron beam, coming from
an accelerator and impinging on a water phantom) consists of the numerical
generation of random histories. To simulate these histories an interaction
model is needed, i.e., a set of diﬀerential cross sections for the relevant inte-
raction mechanisms. The diﬀerential cross sections determine the probability
distribution functions of the random variables that characterise a track: free
path between successive interaction events, the type of interaction taking
place and the energy loss and angular deﬂection for a particular event (and
initial state of emitted secondary particles, if any). With these probability
functions, random histories can be generated by using appropriate sampling
methods. If the number of generated histories is large enough, quantitative
information on the transport process may be obtained by simply averaging
over the simulated histories, and the Monte Carlo method yields the same
information as the solution of the Boltzmann transport equation, with the
same interaction model.
1.3 Current challenges in radiotherapy. State of
the art
Advances in the detection of cancer combined with new techniques have
resulted in a proliferation of new schemes of treatment which reduce the
number of treatment fractions. From a clinical point of view, probably
the greatest revolution during recent years1 has been the development of
extracranial radiosurgery called SBRT (Stereotactic body radiotherapy) or
SABR (stereotactic ablative radiotherapy). Hereinafter this technique will
1According to the PubMed (www.pubmed.org) database, more than 5000 articles re-
lated to SBRT have been published during the last 5 years
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be referred to in the text by either term depending on the original source.
In 2010 the American Association of Physicists in Medicine (AAPM)
published the Task Group TG-101 [32] devoted to SBRT. In the introduction,
the authors state that in order to achieve high conformation around the
volume to irradiate with a rapid fall-oﬀ of the dose, [...] the use of non-
coplanar beams or arcs and sometimes combined with the use of modulated
techniques is a common practice.
The use of non-coplanar beams or arcs can increase the dose conformity
and diminish patient entrance doses within the patient, but it also increases
the delivery time. Treatment time, including time required for patient set-up
and delivery, can range from 15 to 100 minutes [33, 34] depending on the
technique, machine and dose per fraction used.
The magnitude and probability of a tumour base line shift from the
initial set-up to the end of the treatment increases with extended delivery
times [35, 36]. Faster SBRT delivery is therefore not only patient-friendly,
but also improves treatment accuracy and allows for more eﬃcient use of
departmental resources.
Stereotactic ablative radiotherapy (SABR) is widely regarded as the
treatment of choice for early stage lung cancer patients who are medically
unﬁt or decline surgery [37, 38, 39, 40]. In a typical SABR treatment a high
biological dose of radiation is delivered in 3 to 8 fractions (#) over a 2- to
3-week time period. Signiﬁcant improvements in local control have been re-
ported for SABR compared to more conventional radiotherapy (55-66 Gy in
20-33#) delivered over 4 to 7 weeks [41, 42].
Lung treatments have an associated periodic movement of the tumour
related to the patient breathing pattern. Several methods have been deve-
loped in order to deal with lung breathing. The most well known is gating,
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where the respiratory cycle is controlled and the beam is delivered only in
some phases of the breathing cycle. A second method is tracking, where
the MLC is continuously adapted in order to follow tumour motion. The
third option, commonly used, is the deﬁnition of a volume that encloses the
diﬀerent positions where the tumour is located during the respiratory cycle
and the ﬁnal planning volume is based on these merged volumes.
The interplay eﬀect is known as the combination of tumour motion and
beam motion (as it is shaped by a dynamic MLC) that can cause unexpected
hot/cold spots even within the target volume [43]. This has been studied
both theoretically and experimentally since the beginning of modulated tech-
niques [44, 45, 46, 47, 48, 49, 50, 51, 52, 53].
In 2006, Berbeco et al [43] concluded, after irradiation of a ﬁve-beam
lung IMRT plan on a radiochromic ﬁlm situated on a sinusoidal moving
platform, that the standard deviation of the dose to a given pixel in the high
dose region could be around 2-3% and that these diﬀerences were reduced
to 0.3-0.5% after irradiation of 30 fractions.
In 2010 Court et al [50] presented a study based on the irradiation of
a house-made phantom containing twenty micro-MOSFET2s. Their results
showed, that except in complex IMRT and VMAT plans, the diﬀerences
in reading for more than 95% of the points within the tumour model were
less than 2%. In their conclusions they pointed out that for IMRT the
diﬀerences can be reduced by lowering the dose rate and for VMAT plans,
the deviations are eﬀectively reduced when using two arcs instead of one.
In a previous study published the same year [51] the authors related the
amplitude of tumour motion with the ﬁnal deviations as well as associating
2Metal Oxide Semiconductor Field Eﬀect Transistor. It is a dosemeter with low energy
dependence in the MV range, high sensitivity and immediate read out. Not used in this
PhD work.
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the complexity of the plan with the number of MU.
In addition, in 2012 Rao et al [52] presented a study based on the si-
mulation of the interplay eﬀect and showed a lower dosimetric impact of the
intra-fraction motion compared with previous authors. Their conclusions
quantiﬁed the impact of less than 1% of the prescription dose even for treat-
ments of just three fractions. A few months later, Zhao et al [54], concluded
from their analysis on gated lung treatments using a Cyberknife, that the
deviation in the dose of PTV and CTV (clinical target volume) is not always
negligible in gated SBRT. During the last two years, more studies based on
a low number of patients have been presented highlighting the limitation
of the interplay eﬀect on the ﬁnal dose distribution [55, 56, 57]. In 2013
Ong et al [58] found that plans with a unique unﬂattened arc of 10 MV at
2400 MU/min were susceptible to interplay, but not plans with 2 arcs and
more than 2 fractions.
With the new treatment schemes the irradiation time will be extended,
also increasing the possibilities of motion during treatment, known as intra-
fraction motion. One way to reduce the eﬀect of intra-fraction motion is to
reduce irradiation time. This is made possible by removing the ﬂattening
ﬁlter, as ﬁrst proposed in several Monte Carlo (MC) studies and prototype
designs [59, 60, 61, 62, 63, 64]. In 2010 Varian (Varian Medical Systems, Palo
Alto, CA, USA) launched the TrueBeam, a new linear accelerator (LINAC)
designed to irradiate using ﬂattened (FF) and ﬂattening ﬁlter-free (FFF)
beams. Published work on the commissioning of TrueBeam demonstrated
the consistency of this LINAC [65, 66, 67]. Varian supported a group of
the ﬁrst European users in which the author of this thesis formed part. So
far, two diﬀerent works from this group have been published. The ﬁrst
was aimed at studing the suitability of the diﬀerent commercial veriﬁcation
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devices for modulated plans using unﬂattened beams [68] and the second
was an inter-comparison between diﬀerent centres and study of new software
based on Monte Carlo simulations [69]. However, all previous cited studies
have focused on ﬁeld sizes larger than 2 cm x 2 cm.
Modulated beams imply the use of small ﬁelds or segments. Small ﬁelds
have been used in radiosurgery at speciﬁc centres for the last 30 years. Howe-
ver, the expansion of modulated and hypo-fractionated techniques in most
hospitals, has led to the creation of an international working group between
the International Atomic Energy Agency (IAEA) with the collaboration of
the American Association of Physics in Medicine (AAPM), as cited pre-
viously. The aim of this group is to develop standardized recommendations
for dosimetry procedures and detectors in reference dosimetry of small and
non-standard ﬁelds [28].
In parallel with the expansion of the use of small beams, new detectors
have appeared. ionization chambers with reduced volumes can be found in
most medical physics departments (MPD). The initial recomendations from
the manufacturers were their use as relative detectors, but later publications
showed that they can also be used as a reference detector and calibration
factors, kQ,Qo , for these models were proposed.
Analytical and MC kQ,Qo values are derived from the nominal geome-
try of each ionization chamber model since there is no way of knowing the
exact dimensions of each user chamber. In contrast, calibrations in terms
of absorbed dose to water in a standard laboratory can be performed under
similar conditions to subsequent measurements in the user beam, and con-
sequently, the response of each individual chamber is taken into account in
the laboratory. Quality correction factor values have been reported in the
literature for several ionization chambers models [70, 71, 72, 73, 74, 75, 76,
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77, 78, 79, 80, 81, 82, 83, 84, 85, 86]. However, up until now the diﬀerences
between kQ,Qo factors for chambers of the same model, especially for lower
volume ionization chambers, have not been deﬁnitively discussed. In 2013
Andreo et al [87] studied the discrepancies among the kQ values published
for the NE-2571 model based on MC and experimental determinations in
primary laboratories. Recently, a work by Muir [88] analyses experimental
ﬂuctuations in ND,w determined by three accredited dosimetry calibration
laboratories for several ionization chambers including the PTW-30013 and
the NE 2571.
As presented in section 1.2.6, in 2008 [28] a new correction factor kfclin,fmsrQclin,Qmsr
was introduced, which corrects the output ratios (OR) of ionization chambers
to ﬁeld output factors (FOF), as shown in equation 1.15. Since the formative
work by Alfonso et al [28] other authors have presented either experimental
or derived by MC correction factors for a variety of detectors in ﬂattened
(FF) and ﬂattening ﬁlter-free (FFF) beams [89, 90, 91, 92, 93, 94, 95, 96]. In
2012 Ralston et al [97] proposed splitting the correction factor between ge-
ometry/volume eﬀect and the detector material. This allowed quantiﬁcation
and qualiﬁcation of the correction. However, this adds an additional source
of uncertainty.
It is generally understood and all the cited references agree that ioniza-
tion chambers will need a correction factor, kfclin,fmsrQclin,Qmsr , higher than 1 for
small ﬁeld sizes, which is expected due to the volume of any of the actual
commercial chambers. On the other hand, diodes can be developed to a
much smaller size due to their greater sensitivity. However, the response of
these detectors presents a high energy dependence due to their greater den-
sity. The relative contribution of secondary radiation to the measurement
point is higher for small ﬁelds and, as a result, these detectors will have an
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overestimation for small ﬁeld sizes and consequently, diodes will require a
correction factor lower than 1 [98, 99, 100].
In 2014 Francescon et al [90] analyzed the variation of kfclin,fmsrQclin,Qmsr on
percentage depth-dose (PDD) determination for several detectors including
small ionization chambers. However, no references analyzing chamber-to-
chamber diﬀerences of the same type have been presented.
1.4 Aims of the thesis
This PhD thesis is aimed at studing several of the new challenges that me-
dical physics is presently facing. The thesis consist on the analysis of three
main topics.
The impact of geometric inaccuracies in a ionization chamber
on dosimetric parameters
Ionization chambers have been used as reference detectors in clinical practice
for decades. In 2000 a new code of practice [5] was introduced based on the
calibration of the ionization chambers in terms of absorbed dose to water
instead of the previous code based on air kerma determination [101]. One of
the important diﬀerences between the previous protocol [101] and the present
one [5] is that individual diﬀerences between ionization chambers of the same
type are taken into account in the new protocol. In the previous one, the
user had to calculate factors concerning the particular geometry of their
ionization chambers. As it is not possible to know exactly these parameters
for a particular chamber, the values for the diﬀerent dimensions were taken
from the chamber speciﬁcations without consideration of the particularities
of the user ionization chamber.
Not all standard laboratories have linear accelerators with the same user
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beam qualities. One common practice is that the Primary Standard Dosime-
try Laboratory (PSDL) or the Secondary Standard Dosimetry Laboratory
(SSDL) performs a calibration of the user ionization chamber in the beam
quality of the Co-60 source. Some laboratories also provide calibration fac-
tors for the user chamber in other beam qualities whereby correction factors
for a particular beam quality are determined by interpolation. When no ex-
perimental kQ,Qo values are provided, the user can calculate them by using
a set of expressions derived from Bragg-Gray theory and apply analytical
expressions to calculate the overall pQ perturbation factors. It is also possi-
ble to obtain kQ,Qo values by MC simulation as the ratios of fc,Q factor for
two beam qualities as explained previously (section 1.2.4). Analytical and
MC values are derived from the nominal geometry of each chamber model
since there is no way of knowing the exact dimensions of each user chamber.
In contrast, calibrations in terms of absorbed dose to water in a PSDL or
SSDL at diﬀerent beam qualities is the only method where the response of
each individual chamber is taken into account.
Within this framework, this thesis has the following aims:
- Determination of the kQ,Qo values of three thimble ionization chambers
and the study of the inﬂuence of their manufacturing tolerances (ie, cavity
volume, wall thickness...) on kQ,Qo values.
- Determination of the kfclin,fmsrQclin,Qmsr correction factors for the smallest ioni-
zation chamber, PTW-31016, study of the inﬂuence of their manufacturing
tolerances, and analysis of the inﬂuence of the actual ﬁeld size due to jaw
position tolerances.
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Small ﬁeld output factors of the ﬁrst commercial FFF beams
As mentioned previously, small ﬁeld characterisation is challenging. In ad-
dition, FFF beams have been introduced during the last 5 years. Currently
there is no published dosimetric data available on small ﬁeld sizes (0.5 cm x
0.5 cm to 2 cm x 2 cm) for the TrueBeam LINAC. The most closely related
work is by Gete et al [102] in which the authors compare MC simulated 6
MV FFF square ﬁeld output factors from 1 cm on a TrueBeam. In a si-
milar study, Lechner et al [103] published output factor measurements for
an Elekta FFF LINAC. This study aims to determine FOF for four diﬀerent
energies produced by a TrueBeam linear accelerator, two ﬂattened beams
and two unﬂattened and estimate the main sources of uncertainty associated
with small ﬁeld sizes.
Contributions to SABR
The expansion of lung SABR has produced a wide variety in the geometries
and techniques used by diﬀerent institutions. Currently it is possible to ﬁnd
medical departments that use conformed beams, dynamic arcs, IMRT and
also VMAT to deliver the prescribed dose. In this chapter a class solution
using low modulated coplanar arcs and a method to evaluate the combined
eﬀect that modulation and tumour motion (interplay-eﬀect) have on the ﬁnal
dose distribution are proposed. The eﬀect that the use of unﬂattened beams
and the number of breathing cycles have on the ﬁnal dose distribution is also
studied.
As cited previously, several works have been presented since the begin-
ning of modulated techniques on the interplay eﬀect [43, 44, 45, 46, 47, 48,
49, 50, 51, 52, 53, 54]. However, according to the previous references, no
consensus exists at present about the ﬁnal impact of modulated techniques.
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In order to contribute to the evaluation of the interplay eﬀect, PUMA (Pre-
dicted Upshot Motion Analysis) is proposed as an alternative method to
evaluate the interplay-eﬀect. Several modulation indices proposed in the li-
terature are also analyzed to study the suitability of predicting the interplay
eﬀect.

Chapter 2
Materials
This chapter presents the main equipment used in the development of the
thesis and the MC simulation details used in the diﬀerent chapters are also
described.
2.1 Detectors
The main characteristics of the detectors used in this thesis are summarized
in Table 2.1.
2.1.1 Ionization chamber
Three diﬀerent ionization chambers were used for measurements of the ﬁrst
commercial FFF beams (Chapter 5): two from PTW (PTWFreiburg) PTW
31010, PTW31016, and an RK chamber from Scanditronix-Wellhöfer. Fol-
lowing IEC [104] recommendations, each chamber was tested for pre and
postirradiation leakage, stem leakage, stability and possible dependence
of dose rate. The chambers were also cross-calibrated1 against a reference
1Not required for relative determinations
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Ionization chambers
Model
Cavity Cavity Cavity
Wall material and
thickness
Central Waterproof
Volume Radius Length electrode
(cm3) (mm) (mm) diameter
and Material
RK
0.12 2 10
Encapsulation 1
mm
1 mm Al Yes
Scanditronix
50% Epoxy resign
+
50% graphite
PTW-30013 0.6 3.05 23
0.335 mm PMMA
+ 1.1 mm Al Yes
0.09 mm graphite
PTW-31010 0.125 2.75 6.5
0.55 mm PMMA
+ 1.1 mm Al Yes
0.15 mm graphite
PTW-31016 0.016 1.45 5
0.57 mm PMMA
+ 0.3 mm Al Yes
0.09 mm graphite
Diodes
Type Radius Thickness
(mm) (mm)
PFD-
p 1.25 0.45
Silicon. Tungsten powder mixed with
Scanditronix epoxy added behind the chip. Shielded
EFD-
p 1.25 0.45
Scanditronix
Silicon. Unshielded
Edge
n
square
0.03
Silicon Epoxy. Housing wall thickness 0.13 mm brass
0.8mm 2.3 mm aperture in front of the active layer (depletion
SunNuclear length region) 2.1 mm-thick copper substrate
Thermoluminescent detectors
Dimensions Thickness
(mm)
TLD-700 square 3.1 mm 0.9
length 7LiF:Mg;Ti chips
TLD-700R Radius 0.5 mm 6
Radiochromic Film
EBT2 0.28 mm thickness. Calibration using a 48-bit colour (Red channel).
EBT3 Resolution of 72 dots per inch (dpi).
Table 2.1: Summary of detectors used in the diﬀerent studies
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chamber NE25712, in a 6 MV photon beam using the International Atomic
Energy Agency (IAEA) protocol TRS-398 [5]. For the three models a vol-
tage of 300 V was applied and the OR determinations were performed with
a PTWUNIDOS electrometer. RK model was positioned with the stem pa-
rallel to the beam axis, while the PTW-31010 and PTW-31016 were placed
perpendicular to the beam axis in all cases.
Details about PTW-30013 are also included since the impact of the ma-
nufacturing process on kQ,Qo for this model is also analyzed in Chapter 4.
2.1.2 Diode
Shielded and unshielded type p-silicon diodes from Scanditronix of 2.5 mm
diameter and 0.45 mm thickness were used. Accumulated dose, background
signal and fading eﬀects were veriﬁed prior to their use as proposed in the
literature [99]. A Sun Nuclear Corporation Edge Detector diode, with an
active detection area of 0.8 mm x 0.8 mm and a 0.13 mm thick brass housing,
was also used. In all cases readings for OR determinations were performed
with a PTWUNIDOS electrometer.
2.1.3 Radiochromic ﬁlm
Gafchromic EBT2 (International Specialty Products, Wayne, NJ, USA) ra-
diochromic ﬁlm was used for FOF measurements (Chapter 5). Film cali-
bration was performed on a 30 cm x 30 cm slab of Solid Water (Radiation
Measurements Inc.) at 6 MV up to 3 Gy. Scanning was performed on an
Epson 10000XL (Seiko Epson Corporation) scanner in which the inhomoge-
neous response was corrected. Film orientation was also considered. The
ﬁlms were analysed using a 48-bit colour depth and a resolution of 72 dots
2This chamber has a ND,w factor deﬁned by the NPL Laboratory in the range of
TPR20,10[0.568-0.755].
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per inch (dpi). The pixel value in the red channel of the image was used for
calibration [4].
Gafchromic EBT3 was used for SABR veriﬁcations on the Quasar phan-
tom (Chapter 6). The calibration range was extended up to 9 Gy and the
scanning was done on a Vidar scanner. The analysis was performed with the
same resolution as mentioned for the Epson 10000XL. Film Analysis and
comparisons with planned doses as well as dynamic and static irradiations
were carried out using RIT 113 software (Radiological Imaging Technology,
USA).
2.1.4 TLD
The TLDs used were 7LiF:Mg;Ti chips: TLD700R of 1 mm diameter and
6 mm length and also a square TLD700 from Thermo Scientiﬁc of side 3.1
mm and thickness of 0.9 mm. 7LiF detectors were chosen to avoid possi-
ble neutron contributions. Before each irradiation standard annealing was
carried out in a PTWTLD oven: 1 h at 400°C followed by 2 h at 100°C.
The detectors were read using a Thermo Scientiﬁc Harshaw M5500 hot gas
reader. The heating cycle consisted of two stages, a preheating phase at
135°C for 10 s and a reading phase of 10 s from a temperature range of
135°C to 270°C at a linear rate of 25°C s=1. To improve dosemeter accuracy,
individual calibration factors were established for each detector and stability
checks performed periodically with a caesium137 beam. Each experiment
was repeated a minimum of three times in two diﬀerent sessions. The ca-
libration and behaviour of these detectors have been described extensively
elsewhere [105]. The calibration and reading process was performed at Insti-
tut de Tècniques Energètiques (INTE). For all measurements the TLD700R
was placed vertically.
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2.2 Electron linear accelerators
Determinations in Chapter 5 were performed on two TrueBeam LINACs from
two diﬀerent institutions, Institut Català d'Oncologia (ICO) and Edinburgh
Cancer Centre (ECC).
TrueBeam can deliver 6 and 10 MV FF and FFF photon beams. In
FF mode, dose rates up to 600 monitor units per minute (MU/min) in 100
MU/min increments are possible. In 6 MV FFF mode, dose rates from 400
to 1400 MU/min in increments of 200 MU/min are possible and in 10 MV
FFF mode, from 400 to 2400 MU/min in increments of 400 MU/min.
Plans for lung SABR treatment with FF beams (Chapter 6) were per-
formed on a Silhouette (Varian) LINAC with 6 MV with a maximum dose
rate (600 MU/min).
2.3 Treatment planning system
The Eclipse V.10.1 treatment planning system from Varian was used for op-
timization and calculation of SABR treatment plans (Chapter 6). Plans were
optimized with the algorithm Dose Volume Optimizer (DVO) V 10.0.28 and
dose distributions were calculated with the Anisotropic Analytical Algorithm
(AAA V.10.0.28).
2.4 Phantoms
Several phantoms were used depending on the type of measurement. PDDs
and OAR from TrueBeam were determined with ionization chambers and
diodes on a PTW MP3-M water phantom (Chapter 5). These measurements
were repeated on a SunNuclear 3D Scanner.
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FOF determinations with ionization chambers and diodes from True-
Beam (Chapter 5) were determined in a water phantom and in a solid phan-
tom in the case of Radiochromic ﬁlms and TLDs. In order to estimate the
inﬂuence of the phantom material, FOF with ionization chambers were de-
termined in both phantoms.
Quasar phantom
It has been considered useful to present a schematic diagram of the Quasar
phantom (Modus Medical Devices) used in Chapter 6, to facilitate under-
standing of the device.
It is a solid phantom with a cylindrical hole where several inserts can
be placed. In our case, a wooden insert, where a radiochromic ﬁlm can be
placed inside, was used.
The insert is attached to a motor that can move it within the phantom
with an amplitude and frequency selected by the user. Figure 2.1 shows a
schematic diagram.
Figure 2.1: Quasar phantom scheme
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2.5 Monte Carlo Simulation details
MC simulations in Chapters 4 and 5 were performed with the PENELOPE
code system [31]. PENELOPE is coded in Fortran90 and is free and open
source that simulates the coupled transport of photons, electrons and positrons
in the energy range from a few eV to 1 GeV, and in arbitrary materials. The
simulation of photon transport follows the usual analogue procedure, i.e.
all the interaction events in a photon history are simulated in chronological
succession until the photon reaches an energy lower than a user-deﬁned thres-
hold (the absorption energy, Eabs). The simulation of electron and positron
tracks is performed by means of a mixed algorithm. Individual hard" elas-
tic collisions (deﬂections larger than a given cut-oﬀ angle), hard" inelas-
tic interactions (energy loss larger than a given cut-oﬀ, WCC) and hard"
bremsstrahlung emission (energy loss larger than a given cut-oﬀ, WCR) are
simulated by random sampling from the corresponding restricted diﬀerential
cross sections. Energy straggling for inelastic and bremsstrahlung interac-
tions is accounted for in a consistent manner. Thus, electron step size is
selectable by means of user-deﬁned parameters: WCC, WCR are mentioned
above; C1 is the average angular deﬂection; C2 is the maximum average
energy loss; and DSMAX is the maximum allowed step length. Analogue
collision-by-collision electron/positron simulation can be performed by set-
ting C1 = C2 = WCC = WCR = 0. The simulation is fairly stable under
variations of the cut-oﬀs and these can be made quite large, thus speeding
up the calculation considerably, without altering the results. The track of a
particle between successive hard interactions or between a hard interaction
and the crossing of an interface (i.e. a surface that separates two media with
diﬀerent compositions) is generated as a series of steps of limited length.
The combined eﬀect of all (usually many) soft interactions that occur along
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a step is simulated as a single artiﬁcial" soft event (a random hinge) where
the particle loses energy and changes its direction of motion. The energy
loss and angular deﬂection at the hinge are generated according to a mul-
tiple scattering approach that yields energy loss distributions and angular
distributions with the correct mean and variance (ﬁrst and second moments).
Secondary particles emitted with initial energy larger than the absorption
energy (Monte Carlo transport cut-oﬀ) are stored, and simulated after com-
pletion of each primary track. Secondary particles are produced in direct in-
teractions (hard inelastic collisions, hard bremsstrahlung emission, positron
annihilation, Compton scattering, photoelectric absorption and pair produc-
tion) and as ﬂuorescent radiation (characteristic x-rays and Auger electrons).
PENELOPE users can adapt a steering main program in order to deﬁne the
radiation source, the simulation parameters, the quantities of interest to be
scored, variance reduction (VR) techniques to be applied and report the ﬁnal
results. The modular general-purpose main program for PENELOPE named
penEasy [106] has been employed (Version 2009) in this thesis.
To get a reasonably low statistical uncertainty in the dose calculations,
the PSF must contain a relatively large number of particles. The generated
PSFs used in this work stored up to 2 Ö 106 particles per cm2 to ensure that
the statistical uncertainty would be below 0.1% for the dose computation.
In all cases the uncertainty is expressed as 1 standard deviation (sd).
2.5.1 Particle space ﬁles used in kQ,Qodetermination
The energies used in section 3.1.1 were Co, 6 MV, 15 MV and 18 MV. Phase
space ﬁles (PSF) for Co [107], 6 MV [108] were downloaded from IAEA3. In
the case of 15 MV [109] and 18 MV [110], PSFs created at the Institut de
3www-nds.iaea.org/phsp/phsp.htmlx
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Tècniques Energètiques (INTE) were used. In both cases, a Varian Clinac
2100 C/D accelerator head was modelled according to the manufacturer's
speciﬁcations. The initial electron energy, energy spread, and radial intensity
of the beams were tuned so that the calculated PDD and dose proﬁle ﬁtted
the measured PDD curves and lateral proﬁles in water.
2.5.2 TrueBeam Particle space ﬁles
The PSF recorded just above the movable jaws, and ﬁles containing infor-
mation on the geometry and movement of the jaws, were provided by Varian
(Varian Medical System) for the four energies 6 and 10 MV FF and FFF
beams. Initial simulations of four square ﬁelds were performed (0.5, 1, 2 and
10 cm side length).
To reduce computation time the simulations were carried out in two
stages. Firstly, particles were tracked through the treatment head and stored
in a PSF at 70 cm. Secondly, dose distributions in the phantom were calcu-
lated using these new PSF as the particle source.
2.5.3 Determinations in water
Cylindrical voxels of 0.5 mm radius and 2 mm length were deﬁned for all
determinations of absorbed dose in water.
2.5.4 Dose to ionization chamber air cavity determination
The photon energy cut-oﬀ was set to 1 keV for all materials throughout
the entire geometry, whereas those for charged particles were made zone-
dependent as described below. The threshold energies for charged particle
radiative and inelastic collisions were set equal to the cut-oﬀ energies. The
parameters C1 and C2, modulating the limit between detailed and condensed
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Measurement type Shape X (mm) Y (mm) Z (mm)
OAR 1 cm x 1 cm Cuboids 2 0.5 0.5
OAR 10 cm x 10 cm Cuboids 10 0.5 0.5
detector accuracy
3 x 3 Matrix
1 1 2
of cuboids
r (mm)
Field Output Factor Cylindrical 0.5 2
PDD Cylindrical 1 0.5
Table 2.2: Shape and size of the voxels used in the TrueBeamMC simulations
charged particle transport simulation, were set to 0.1 for surrounding water
and stem (more than one cm away from the air cavity) and detailed simu-
lation of charged particles(C1=C2=0) was performed on the material walls,
air cavity and central electrode. The geometry to be simulated for each
detector was split into two regions, the ﬁrst was a spherical volume with a
radius of 2 cm around the detector (hereafter called the region of interest,
ROI) and the second region was the rest of the geometry. Within the ROI,
a cut-oﬀ energy of 10 keV was selected for the charged particles, outside the
ROI, a cut-oﬀ energy of 200 keV was applied in order to satisfy a radiation
(bremsstrahlung) yield below the intended uncertainty of the calculations,
0.15% (Type A) in the scored absorbed dose.
2.5.5 Monte Carlo Simulation voxel details on TrueBeam de-
terminations
As will be described in section 3.2.1, PDDs and OAR for 1 and 10 cm side
length were simulated by MC and compared with measurements performed
with diﬀerent detectors. Table 2.2 shows the voxel shape and size deﬁned at
the four energies for FOF, OAR and PDD determination.
Chapter 3
Methodology
This chapter describes the procedures undertaken with the equipment de-
scribed in chapter 2 to develop the three main topics studied in this thesis
and whose results are presented in chapters 4 to 6.
3.1 The impact of geometric inaccuracies on dosi-
metric parameters in an ionization chamber
Ionization chambers are the most common detector used in medical physics
departments to determine all the dosimetric parameters necessary to cha-
racterize beams. As previously presented in the introduction, the absorbed
dose determination in reference conditions with ionization chambers requires
knowledge of several factors such asND,w,Qo, kQ,Qo , which can be determined
in PSDL or SSDL. In addition, the new correction factor kfclin,fmsrQclin,Qmsr proposed
by Alfonso et al [28] must also be considered in small-ﬁeld dosimetry.
This section describes the methodology used to estimate the diﬀerences
that can exist between the correction factors kQ,Qo and k
fclin,fmsr
Qclin,Qmsr
due to
geometrical manufacturing diﬀerences in chambers of the same type . Ana-
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lysis of kQ,Qo is performed for three waterproof models of diﬀerent volume
and the study of kfclin,fmsrQclin,Qmsr is centred on the ionization chamber with the
smallest cavity volume analysed (0.016 cm3). Both studies are based on the
geometrical tolerances that each model has.
3.1.1 kQ,Qo determination
Three waterproof ionization chambers models from PTW were selected,
PTW-30013, PTW-31010 and PTW-31016. The main characteristics can
be found in Table 2.1. Detailed information on the geometry and tolerance
dimensions were obtained from the manufacturers. For each of the three
PTW models, three diﬀerent geometries were deﬁned and labelled nomi-
nal, maximum and minimum. The nominal geometry was deﬁned using the
nominal dimensions and maximum and minimum geometries refer to the
maximum and minimum air cavity volume, respectively. They were deﬁned
by modifying the wall diameters and length of the walls and central elec-
trode, i.e., the maximum geometry was deﬁned with the maximum cavity
walls and the minimum dimensions for the central electrode and the mi-
nimum geometry with the minimum cavity walls and the maximum central
electrode. The diﬀerences between internal and external wall thickness were
applied by maintaining a ﬁxed thickness of graphite and applying the varia-
tions to the PMMA for all the geometries deﬁned. Figure 3.1 is a schematic
diagram of the geometries deﬁned (nominal, maximum and mínimum) from
the information provided by the manufacturer.
kQ,Qo values were obtained by MC simulation following the approach
proposed by J Sempau et al [23], where the fc,Q factor was deﬁned as a
proportionality factor relating the absorbed dose in water with the mean
absorbed dose in the detector air cavity (equation 1.11).
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Figure 3.1: Diagram of the three considered geometries deﬁned from the
tolerances in the dimensions provided by the manufacturer. (Dimensions
and tolerance values are not shown because of conﬁdentiality agreements
with the manufacturer)
Consequently, kQ,Qo , can be evaluated as the ratio of fc,Q for two diﬀerent
beam qualities:
kQ,Qo =
fc,Q
f c,Qo
(3.1)
A fourth non-waterproof model from Nuclear Enterprise (NE2571) was
used to validate the consistency of the methodology applied. This model was
selected to test the MC simulation process due to the great amount of data
available in the literature and also because of its small geometrical tolerance
in comparison with the other three ionization chambers studied.
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3.1.2 Geometrical inﬂuence on kfclin,fmsrQclin,Qmsr determination for
PTW-31016
The eﬀect that geometrical tolerances from the manufacturing process have
on kfclin,fmsrQclin,Qmsr are examined in the smallest chamber (PTW-31016). Accor-
ding to Alfonso et al [28], kfclin,fmsrQclin,Qmsr correction factors are not expected to
exhibit an energy dependence in the case of ionization chambers, and this
point will be discussed in Chapter 5. The study was performed with a 10
MV FFF beam, which has the most inhomogeneous dose distribution for
current beams delivered by LINACs. Thus, this energy was chosen in order
to obtain an upper limit for this eﬀect.
The correction factor, for each ﬁeld size, was obtained as the ratio be-
tween the FOF obtained in a water phantom and the ratio of the mean
absorbed dose in the air cavity for each ﬁeld size, while the reference ﬁeld
size was ﬁxed at 10 cm x 10 cm. Equation 3.2
kfclin,fmsrQclin,Qmsr = k
fclin,f10x10
Qclin,Q10x10
=
D
fclin
w,MC/D10x10w,MC
D¯
fclin
air,MC/D¯10x10air,MC
(3.2)
Where Dfclinw,MC represents the absorbed dose in water for a ﬁeld size f
simulated by MC and D¯fclinair,MC is the mean absorbed dose in the ionization
chamber air cavity. The subindex MC was added to clarify that in all cases
values are obtained by MC simulation.
Backscatter on the jaws and ionization chambers needs to be considered
when FOF are determined by MC simulation. Some authors have estimated
it to be 1.5% in small ﬁelds [111]. On the other hand, some authors have
found good agreement between MC determinations and experimental mea-
surements without taking it into consideration [102]. The method proposed
here to determine correction factors removes the inﬂuence of backscatter on
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the monitor chamber since the eﬀect would equally aﬀect both of the terms
of the ratio in equation 3.2.
3.1.3 Set-up accuracy in kfclin,fmsrQclin,Qmsr determination
The set-up position of the chamber during measurements is especially critical
when using small ﬁelds. The option that has been used in all experimental
determinations with active dosemeters has been to position the detector
at the site that maximizes the reading. It is understood that the same
approach is necessary in MC simulations, to set-up the ionization chamber
at the position that maximizes the reading in the ionization chamber.
According to the values provided by the manufacturer, PTW-31016 has
a nominal diameter equal to the cavity length. However, the tolerance of the
cavity length is much higher than for the diameter. As a consequence, the
three geometries deﬁned for this model diﬀer mainly in the cavity length as
shown in Figure 3.2.
Although this section aims to determine kfclin,fmsrQclin,Qmsr theoretically by MC,
where the geometry can be deﬁned exactly, it is important to take into
account the fact that Varian assigns a 0.5 mm tolerance to the LINAC jaw
position and consequently the ﬁeld size tolerance must also be considered
before using these values for experimental determinations. In order to study
the eﬀect that these tolerances have on the kfclin,fmsrQclin,Qmsr correction factor,
kfclin,fmsrQclin,Qmsr was also determined for a ﬁeld size of 0.45 cm side length. As-
suming that the eﬀect increases when ﬁeld sizes diminish, only the 0.45 cm
size was considered.
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Figure 3.2: Schematic diagram of the three geometries deﬁned for PTW-
31016. With detail of the origin coordinates assigned for each geometry
3.2 Small ﬁeld output factors for ﬁrst commercial
ﬂattened ﬁlter free beams
A set of preliminary studies were performed with several detectors and also
the PSFs (see section 2.8) from TrueBeam were veriﬁed. The experimental
FOF determination for ﬁeld sizes up to 2 cm side length were compared with
values from MC simulations.
The main sources of uncertainties (jaw and detector set-up) in small ﬁeld
output factor determination were also studied.
3.2.1 Preliminary veriﬁcations
To validate the results above 2.5 cm square length, where there is published
data available [67, 65, 66], FOF and tissue phantom ratio at 20 and 10 cm
depth (TPR20,10) were compared for the four energies studied. Percentage
depth dose (PDDs) and oﬀ axis ratios (OAR) for 1 and 10 cm side length
were simulated by MC and compared with measurements performed on a
PTW MP3-M water phantom with four detectors: two ionization chambers
(PTW31016 and RK) and two semiconductor detectors (Edge and PFD).
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Gamma analysis [112] at 2%, 2 mm was used to compare MC with the
response of the diﬀerent detectors. OAR for all energies were measured at a
SDD of 100 cm at 5 cm and 10 cm depth and normalised to the maximum.
The results were compared with MC on square ﬁelds of 1 and 10 cm length.
3.2.2 Output ratios determination
Output ratios (OR) were determined in isocentric conditions at 5 cm depth
for 6 MV and 6 MV FFF and at 10 cm for higher energies. They were mea-
sured for square ﬁelds ranging from 0.5 cm x 0.5 cm to 10 cm x 10 cm for
the four energies. OR were determined using nine detectors: three ioniza-
tion chambers: PTW-31010, PTW 31016 and RK; three diodes: Edge, PFD
and EFD; radiochromic ﬁlm EBT2 and two TLDs: TLD700 and TLD
700R (TLD-700R was only used for the small ﬁelds). For active detectors
the readings recorded on the detector at sub-millimetre displacements of the
TrueBeam treatment couch were used to establish the location of maximum
output, otherwise known as the set-up isocentre. To estimate the uncertainty
in OR values due to detector position, three measurements were taken at the
centre of the ﬁeld and at four points +/- 1 mm along the X and Y axes for
each ﬁeld size. The charge reading in the centre was used for calculation
of the FOF and the relative uncertainty was estimated as the standard de-
viation of the ﬁve diﬀerent measurement positions. The uncertainty of the
radiochromic ﬁlm was estimated from the standard deviation of the mean
pixel value at a radius of 1 mm around the set-up isocentre. Five measure-
ments were taken using the TLDs and repeated on two diﬀerent days.
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3.2.3 Field Output Factor determination for square ﬁelds
larger than 2 cm side length
The correction factor, kfclin,fmsrQclin,Qmsr , was set to unity for square ﬁelds equal to,
or greater than, 2.5 cm side length and consequently FOF were equal to
OR.
In this text fref , fmsr are equal to 10 cm x 10 cm square ﬁeld size and
consequently, from equation 1.16
ORfclinfref = OR
fclin
f10cmx10cm
=
MfclinQclin
MfmsrQmsr
=
MfclinQclin
M10cmx10cmQ10cmx10cm
(3.3)
3.2.4 Field Output Factor determination for square ﬁeld sizes
up to 2 cm side length
As previously metioned, the dosimetric characterisation of small ﬁelds is chal-
lenging due to the active volume and non-water equivalence of any detector
combined with the lack of lateral charged particle equilibrium [24]. In addi-
tion, the eﬀect of small changes on the ﬁeld size due to machine calibration
also needs to be considered.
Our strategy to overcome these diﬃculties was to calculate the ﬁeld out-
put factors by MC simulation using the nominal ﬁeld sizes and to determine
experimentally all the output ratios for the detectors with a smaller volu-
me. PTW-31016 was chosen because it was the smallest ionization chamber
available and the low energy dependence on the kfclin,fmsrQclin,Qmsr correction factors
expected for this type of detector [28]. The kfclin,fmsrQclin,Qmsr presented in Figure
4.3 for the nominal model were applied on the OR at the four energies and
the results compared with the values obtained with the other detectors. Ion
recombination factor diﬀerences were considered as part of the ﬁnal uncer-
tainty, which were expected to be less than 0.5% [113, 114]. TLD-700R and
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radiochromic ﬁlm correction factors were considered to be equal to 1 for all
ﬁeld sizes and energies.
3.2.5 Geometric set-up inaccuracies
The main source of set-up inaccuracies was analyzed separately by examining
the detector set-up and inaccuracies in the jaw set-up.
Detector set-up
The inﬂuence of the PTW-31016 set-up was studied during the determination
of kfclin,fmsrQclin,Qmsr by MC simulation as described in section 3.1.3. A more general
detector set-up analysis was performed for the FFF energies using a 1 mm
x 1 mm x 2 mm voxel matrix deﬁned around the geometrical centre of the
beam at reference depth.
Jaw set-up
In order to consider the 0.5 mm tolerance on the jaw position (section 3.1.3 ),
two square ﬁelds of 0.45 cm and 0.49 cm side length were deﬁned at all
energies to study their inﬂuence on FOF determination by MC simulation.
Validation
To corroborate the inﬂuence of jaw inaccuracies predicted by MC, OR were
determined with both the Edge detector and the TLD-700R on a second
TrueBeam at another institution. These detectors were selected to record
the output readings because of their greater spatial resolution. It is under-
stood that diﬀerent LINACS, especially from diﬀerent institutions, will have
submillimetric diﬀerences in ﬁeld size. The original values were measured at
the ICO and the second LINAC chosen was at ECC.
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3.3 Contributions to SABR treatments
Previous paragraphs present the studies to improve the determination and
analysis of dosimetric parameters related with the determination of absorbed
dose in reference conditions and also in small ﬁelds. This paragraph describes
the methodology proposed to improve planning of lung SABR. The main
characteristics of SABR have already been introduced in section 1.3.
The studies presented were performed during the implementation of the
lung SABR technique in ECC. Some important decisions were taken prior
to the introduction of SABR in ECC, such as reducing treatment time as
much as possible and developing a standard solution (class solution) valid
for most patients. As explained in the introduction, the reduction of the
total treatment time implies the use of coplanar beams or arcs, otherwise,
a signiﬁcant part of the time will be spent rotating the couch. Continuous
irradiation without the application of gating or tracking was also ﬁxed in
advance.
In order to ﬁnd a solution valid for a high percentage of patients, a certain
level of modulation is required. The interplay eﬀect must be considered when
modulated plans are delivered, particularly when it is clearly known that the
PTV for a lung will have intra-fraction movements due to the breathing cycle.
Present CT scanners allow the generation of a collection of several CT
images covering the breathing cycle which are used to ﬁx the motion and
deformation of the tumour and also to know the breathing parameters for
each patient. Internal Target Volume (ITV) deﬁnition can be performed us-
ing a special reconstruction that some CTs perform (the maximum intensity
projection), merging the GTVs (gross tumour volume) structures deﬁned
on diﬀerent phases of the respiratory cycle or a mix of the former options.
Finally, the PTV is deﬁned by adding an appropriate margin to the ITV.
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A schematic diagram of a target volume is presented in Figure 3.3 to-
gether with the inﬂuence of periodic volume motion during irradiation in the
ﬁnal dose distribution. The continuous line in Figure 3.3 corresponds to the
planned dose distribution. However, because of the periodic motion of the
volume, the ﬁnal dose distribution will be represented by the dotted line.
Dose distribution in zone A is related to the motion amplitude and is almost
independent of the modulation of the plan, it would be aﬀected by the total
number of cycles during irradiation and would become independent of it for
a high number of breathing periods as will be discussed later. Zone B is the
zone that would include the GTV. Volume motion during irradiation should
not aﬀect the ﬁnal dose distribution in zone B for a ﬂattened conformed
beam, and would produce a smoothing of the peak for the unﬂattened con-
formed beams compared with the static situation. Final dose distribution
in zone B can potentially be greatly inﬂuenced by the motion of the volume
for a modulated plan (IMRT/VMAT) since not all points in this zone are
continuously and homogeneously irradiated. Thus, this zone is where the
suitability of modulated plans must be studied. Gating techniques should
be used in case eﬀects in zone A wish to be reduced, such techniques will
also aﬀect the ﬁnal dose distribution in zone B.
The proposed conﬁguration to irradiate lung SABR treatments with low
modulated arcs is ﬁrst introduced, followed by the basis of PUMA, the
method to evaluate the suitability of modulated lung SABR plans due to
the interplay eﬀect. Finally, there is a study of the published modulation
indices to evaluate the interplay eﬀect.
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Figure 3.3: Diagram of target volume deﬁnition and the eﬀects of periodic
volume motion during irradiation on the ﬁnal dose distribution. Internal
Target Volume (ITV) is deﬁned by encompassing the Gross Tumour Volume
(GTV) in the diﬀerent breathing phases. Planning target volume (PTV) is
deﬁned by applying an appropriate margin to the ITV. Solid line represents
a proﬁle of the planned beam on the projection of PTV and the dotted line
represents the ﬁnal dose distribution on that plane as a consequence of a
periodic target motion on the left-right direction
3.3.1 The eﬀect of low modulated plans
Plan set-up proposed is based on four coplanar 6 MV arcs of 200°220° cen-
tred at the centre of the tumour, two clockwise and two counterclockwise
with two diﬀerent collimator rotations, starting or ﬁnishing on the back of
the patient (180°). To study the eﬀect of the modulation on the interplay
eﬀect, a new plan with a lower modulation was created for 6 patients. Low
modulation reduces the eﬀect of tumour motion on the ﬁnal dose distribu-
tion, allowing the maximum dose in the GTV to be kept below 125% of the
CHAPTER 3. METHODOLOGY 51
prescribed dose (SABR protocols admit a maximum of 140% of prescription
dose within the ITV) [115] . This is achieved in the Eclipse TPS by forcing
a reduction in monitor units (MU) during optimization. This conﬁguration
implies that gantry speed for low modulated plans is close to the maximum,
and represents between 8.5 and 10 breathing cycles during each arc irradia-
tion. The advantages of including a minimum of 8 breathing cycles will be
presented later.
4DCT data sets were used to create VMAT plans from Eclipse (V.10.1).
The modulation indices of the 12 initial plans were scored using ALPO (Ave-
rage Leaf Pair Opening). Veriﬁcation plans were calculated on the Respira-
tory Quasar phantom (Modus Medical Devices) and irradiated on a LINAC
Silhouette. Radiochromic ﬁlms (EBT3) placed in the phantom were irra-
diated and analyzed. Each plan was delivered twice on the phantom, the
ﬁrst one with no movement and the second one using ﬁxed parameters (1 cm
peak to peak, 12 breaths per minuteBPM). Because of the dose saturation
that the red channel of radiochromic ﬁlm has to high doses, the delivered
dose was 1/3 of the prescribed dose per fraction on the 18 Gy/# plans and
1/2 for the 11 Gy/#.
A relative comparison of dose distributions between the measurements
and TPS was performed. The criteria for evaluation were set to be < 5%
of points with γ(3%, 3mm) > 1 [112] on the comparison between static
and dynamic dose distributions recorded on radiochromic ﬁlms inserted in
the Quasar phantom. This method was ﬁxed as the standard method to
analyze the interplay eﬀect for all SABR patients. A threshold of 90% of the
maximum was ﬁxed since the aim of the analysis was to study the inﬂuence
of the modulation on the ITV (Zone B on Figure 3.3). As the maximum dose
on the plan is approximately 115-120% of the prescribed dose, the chosen
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threshold approximately represents the prescription dose.
After the acquisition of a TrueBeam at ECC, a new class solution was
proposed with just two arcs for the 10 MV FFF, considering the higher dose
rate for this energy (2400 UM/min) which implies a similar time per arc,
but a reduction in the total treatment time.
3.3.2 Number of breathing cycles included in each arc
A consequence of the irradiation during breathing is an enlargement of the
penumbra (zone A on Figure 3.3). To study the inﬂuence of the fraction of a
cycle included in the total number of breaths during an arc delivery, a convo-
lution of the static beam proﬁle using a sinusoidal function, which represents
a simpliﬁcation of tumour motion was calculated for the most unfavourable
situation (n complete cycles plus half). The diﬀerence between one com-
plete cycle (or n) and n and a half, was scored, and the minimum number
of breathing cycles (n) included on an arc to have the maximum diﬀerences
in the dose lower than 2% were found for the 3 more common energies used
in SABR treatments, i.e. 6 MV from a conventional linear accelerator and
6 MV and 10 MV unﬂattened beams from a Varian TrueBeam.
3.3.3 Basis of PUMA method
The method used to evaluate the interplay eﬀect on lung SABR patients
with the Quasar phantom is time consuming and also requires a minimum
of one hour of treatment machine time to set-up the phantom and perform
the two irradiations in static and dynamic mode, as explained previously.
In addition, the radiochromic ﬁlm scan is recommended to be performed a
minimum of 6 hours after the irradiation. Because of these limitations an
alternative method named as PUMAPredicted Upshot Motion Analysis was
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developed.
The method is based on the translation of the periodic breathing cycle
of the PTV to the beam. It consists of two main steps: ﬁrst, each arc
of the initial plan is split into sub-arcs of 3°. Subsequently, the plan is
exported and in-house software developed using Matlab (Mathworks) creates
two new plans, the ﬁrst one applies a sine function to the cranio-caudal
coordinate of the isocentre of each sub-arc and a second plan applies a cosine
function (Figure 3.4). The absorbed dose distributions of these two new
plans (sine and cosine) are calculated and compared with the initial planned
distribution.
Figure 3.4: Diagram of the split of the arcs and periodic change in the cranio-
caudal direction. Period equal to 27° of the original arc that corresponds to
9 sub-arcs
It is important to notice that in routine clinical practice, the irradia-
tion starts without ﬁrst checking the phase of the breathing cycle, and con-
sequently this approach allows the analysis of the interplay eﬀect in two
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opposite situations.
The frequency of the sine and cosine functions is calculated from the
gantry speed of the arcs (4.5°/s) and 12 BPM is assumed (see Figure 3.4).
This implies the equivalence that a breathing cycle corresponds to 27°. These
two new plans are imported again to the treatment planning system and
dose distributions are compared with the split arcs planned with a unique
isocentre.
Using the TPS tools a subtraction of the original dose distributions with
the sine or cosines plan is performed and the percentage of the ITV volume
with dose diﬀerences higher than 3% of the prescription dose on the ITV is
scored. In all cases the most unfavourable case is recorded.
Acceptance criteria
The criteria for evaluation are set to be less than 5% of points with more
than 3% dose diﬀerence between plans created by PUMA and the split plans
with the original isocentre inside the ITV.
Evaluation
To test the viability of the PUMA method to evaluate the interplay eﬀect on
lung SABR modulated treatments, 23 plans were evaluated with PUMA and
compared with the results obtained with the method proposed as standard
(radiochromic ﬁlms in Quasar). The 23 plans evaluated are the 12 plans pre-
sented in section 6.1.1, six more low modulated plans and ﬁve plans created
with 10 MV FFF and two arcs.
Several indices have been proposed in the literature in order to estimate
the complexity of a modulated plan which could also imply a higher inter-
play eﬀect. The selected indices to be analyzed were ﬁrstly the Modulation
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Complexity Score (MCS) introduced by McNiven in 2010 [116] as one of the
ﬁrst indices proposed; secondly the Modulation Index Total (MIt) proposed
in 2014 by Park [117] which introduces speed and MLC acceleration and
ﬁnally the Aperture Irregularity (AI), Aperture irregularity was introduced
by Du in 2014 [118] which analyzes the non-circularity of the MLC aper-
tures. These indices were calculated with Matlab software developed by V.
Hernandez and J. Saez.
Possible linear correlation between the mentioned indices and radiochromic
ﬁlms was analyzed [119] and a statistical analysis of their sensitivity and
speciﬁcity was performed.

Chapter 4
The impact of geometric
inaccuracies on dosimetric
parameters. Results and
discussion
The results presented have been obtained following the methodology detailed
in section 3.1. MC simulation details can be found in section 2.5.
4.1 Previous veriﬁcations
kQ,Qo factors were determined for NE2571 by MC simulation. Results are
presented in Figure 4.1 and compared with previously published results.
According to the present comparison, the good agreement between the results
of these simulations and those reported by others implies that the phase space
ﬁles, the simulation parameters and the methodology used were appropriate.
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Figure 4.1: kQ,Qo determined for NE-2571 compared with previously pub-
lished values. Lines indicate a polynomial function proposed by the authors
based on analytical expressions (TRS-398) or MC simulation
4.2 Geometric inﬂuence on reference conditions
The relative diﬀerence in cavity volume between the nominal, maximum or
minimum geometry increases, as expected, for smaller ionization chambers.
However, the larger tolerance of both the radius and length of the central
electrode for PTW-31010 in comparison with PTW-31016 causes a major
diﬀerence in the cavity volume for the maximum geometry for this model.
Due to the conﬁdentiality agreement with the manufacturer, Table 4.1 only
shows the percentage volume diﬀerence from the nominal on the central
electrode and internal cavity without considering the central electrode for
the geometries deﬁned for the three PTW models.
fc,Q factors for the diﬀerent energies and geometries studied are pre-
sented in Table 4.2. Diﬀerences in fc,Q within the same model are less than
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Model Geometry Central electrode Internal cavity* Cavity volume
PTW-30013 Nominal 22.02 mm3 637.10 mm3 615.1 mm3
Maximum - 3.4% + 3.3% + 3.6%
Minimum + 3.5% - 3.9% - 4%
PTW31010 Nominal 4.42 mm3 134.33 mm3 126.55 mm3
Maximum - 16% + 36% + 40%
Minimum + 21% - 11% - 15%
PTW-31016 Nominal 0.11 mm3 15. 96 mm3 15.85 mm3
Maximum -34% + 22% + 23 %
Minimum + 42% - 22% - 22%
*Cavity deﬁned by the walls; Cavity volume = Internal cavity - Central electrode
Table 4.1: Nominal volumes and percentage volume diﬀerence, from nomi-
nal geometry, for central electrode, internal cavity without central electrode
consideration and cavity volume for the geometries deﬁned
0.4% ± 0.2%. The maximum diﬀerence is found for PTW-31016 and is much
lower than the relative diﬀerences in cavity volume which are approximately
23%.
Model
Geometry Nominal energy (TPR20,10)
Co 6 MV
(0.674)
15 MV
(0.757)
18 MV
(0.778)
PTW-30013 Nominal 1.111 1.100 1.089 1.081
Maximum 1.113 1.102 1.087 1.080
Minimum 1.110 1.101 1.086 1.079
PTW-31010 Nominal 1.122 1.110 1.088 1.089
Maximum 1.126 1.111 1.088 1.092
Minimum 1.119 1.107 1.087 1.087
PTW-31016 Nominal 1.134 1.119 1.100 1.092
Maximum 1.136 1.119 1.101 1.092
Minimum 1.136 1.116 1.097 1.089
NE-2571 Nominal 1.109 1.101 1.083 1.080
Uncertainties in all values are smaller than 0.15% (1 sd)
Table 4.2: fc,Q factors determined by simulation at the diﬀerent energies for
the diﬀerent geometries deﬁned in each ionization chamber
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The results shown in Table 4.2 imply that the impact of geometric in-
accuracies in the manufacturing process mainly aﬀect the calibration factor
ND,w,Qo of each chamber while their impact on the kQ,Qo factors is much
smaller, as can be seen in Table 4.3.
Model Geometry
Nominal energy (TPR20,10)
6 MV (0.674) 15 MV
(0.757)
18 MV
(0.778)
PTW-30013
Nominal 0.991 0.981 0.973
Maximum 0.990 0.977 0.970
Minimum 0.992 0.978 0.972
PTW-31010
Nominal 0.990 0.970 0.970
Maximum 0.987 0.967 0.970
Minimum 0.989 0.971 0.972
PTW-31016
Nominal 0.987 0.970 0.963
Maximum 0.985 0.969 0.961
Minimum 0.983 0.966 0.959
NE-2571 Nominal 0.993 0.977 0.974
Uncertainties in all values are smaller than 0.2% (1 sd)
Table 4.3: kQ,Qo factors determined by simulation at the diﬀerent energies
for the diﬀerent geometries deﬁned in each ionization chamber
From the results presented in Table 4.3 it can be concluded that the
diﬀerences in kQ,Qo due to the manufacturing process of any of the three
PTW models studied is less than 0.5% (±0.2% - 1 sd).
A comparison of the kQ,Qo factors presented in Table 4.3 with values
published in the literature was carried out, the results are presented in Figure
4.2. Only experimental data from primary laboratories and MC simulation
results are considered.
As shown in Figures 4.1 and 4.2, the diﬀerences among diﬀerent publi-
cations are larger than the inﬂuence of geometrical tolerance found in the
present study (Figure 4.2). The dispersion between published values could
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Figure 4.2: kQ,Qo factors determined by the three geometries deﬁned for
each model compared with previously published values. Lines indicate a
polynomial function proposed by the authors based on analytical expres-
sions (TRS398) or MC simulation. Kapsch and McEwen corresponds to
experimental values from PSDL
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be related to small diﬀerences or simpliﬁcations during deﬁnition of the geo-
metry and simulation parameters, and also due to diﬀerences in material
composition between chambers of the same model for the experimental pu-
blished values. Our results indicate that diﬀerences in the active collecting
volume for the three PTW ionization chambers aﬀects the ND,w,Qo coeﬃ-
cients to the same proportion (see equation 1.6), and that their inﬂuence
on the kQ,Qo is less than 0.5%. The dispersion in the ND,w,Qo obtained in
our work is in agreement with what was recently published by Muir [88].
In his study he also analysed diﬀerences in the manufacturing process and
variations due to stability over time for four models including PTW-30013
and NE-2571. From his data, it is not possible to know the variability of
volumes in the experimental ionization chambers analyzed. However, the
maximum diﬀerences in ND,w,Qo from the average is approximately 4% for
PTW-30013. This result agrees with the percentage diﬀerence in volume
between maximum/minimum and nominal geometries deﬁned in our study
for this model.
Diﬀerences in sw,air,Wair between two clinical MV photon beam qualities
are assumed to be negligible and consequently the diﬀerences in kQ,Qo in
chambers of the same type are reduced to ratios of perturbation factors
(equation 1.9). The inﬂuence of the diﬀerent perturbation factors (detailed
in equation 1.10) on kQ,Qo was analyzed as the ratio of perturbation factors
for two beam qualities.
According to literature previously cited, pcav has been ruled out as a
possible cause of chamber-to-chamber diﬀerences since it is considered to be
equal to 1 independently of photon beam energy with an uncertainty lower
than 0.1%.
Variations in the central electrode thickness, for the three models se-
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lected, are small in comparison with diﬀerences studied in previous publica-
tions [22]. Thus, according to the proposed values [22, 9] pcel cannot explain
the diﬀerences found between chambers of the same type.
pdis has an explicit dependence on both the energy and internal cavity
radius [13]. However, diﬀerences calculated in pdis,Q/pdis,Qo ratios for the
geometries of the same model would imply a much lower eﬀect (diﬀerences
found were below 0.01%).
As previously explained, variations in wall thickness were applied by ﬁx-
ing the graphite thickness and changing the PMMA thickness. The diﬀeren-
ces found in pwall,Q/pwall,Qo range from 0.02% for 6 MV to up to 0.31% for
15 MV. These values are of the same order as the kQ,Qo variations found in
our study. Therefore, considering the uncertainties of our results, we could
assume that the wall perturbation factor, pwall, is mainly responsible for the
kQ,Qo diﬀerences between chambers of the same model. However, pwall ratios
calculated for the diﬀerent energies do not explain why the calculated kQ,Qo
values do not follow the expected sequence: kQ,Qo(max) < kQ,Qo(nom) < kQ,Qo(min).
Nevertheless, fc,Q factors presented in Table 4.2 show the espected be-
haviour, i.e., fc,Q values are larger when the cavity volume increases. All in
all, it is worth pointing out that the observed diﬀerences between kQ,Qo for
the same model are of the same order as their associated uncertainties.
Calibration factor diﬀerences between chambers of the same type can
be caused by small diﬀerences in geometry and also diﬀerences in materials
and the manufacturing process over the years. In recent years, several com-
pilations of experimental kQ factors have been published in the literature
[82, 85, 120, 121] as well as other studies based on MC simulations [83, 122],
which allow for a comparison with experimental data. In all cases uncertain-
ties of kQ,Qo factors were estimated up to a maximum of 0.5%. Apart from
CHAPTER 4. IMPACT OF GEOMETRIC INACCURACIES 64
the geometric tolerance studied here, diﬀerences between published results
in the literature could also be aﬀected by geometry deﬁnition, materials and
transport radiation parameters in MC simulation and also by small diﬀer-
ences in material composition for experimental studies.
4.3 Geometrical inﬂuence on kfclin,fmsrQclin,Qmsr determina-
tion for PTW-31016
The inﬂuence of geometrical tolerances on the manufacturing process was
studied, as in the previous section, by the deﬁnition of the three geometries
for the PTW-31016 model, the smallest ionization chamber studied.
kfclin,fmsrQclin,Qmsr were determined, as explained in section 3.1.2, at 10 MV FFF
following equation 3.2. In this section the correction factor diﬀerences caused
by the small diﬀerences in the geometry will be discussed. The kfclin,fmsrQclin,Qmsr
values obtained for the nominal geometry will be applied and discussed in
Chapter 5.
Prior to the kfclin,fmsrQclin,Qmsr determination for the smallest ﬁeld sizes by MC,
the position that maximizes the mean absorbed dose in the ionization cham-
ber cavity was determined by applying sub-millimetre variations in the lon-
gitudinal set-up coordinate of the ionization chamber. The point that maxi-
mizes the reading was found at 0.3 mm in the stem direction from the origin
deﬁned in the ionization chamber manual for the nominal geometry (Figure
3.2). However, the maximum response was not found in the same position for
the three geometries. Diﬀerences in position were due to how the geometries
were deﬁned. Table 4.4 shows the correction factors determined, following
equation 3.2, for the three geometries for the 0.45 and 0.5 cm side lengths.
One set of data is for where the geometries were centred according to the
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Geometry
Field Size
0.5 cm x 0.5 cm 0.45 cm x 0.45 cm
Origin 0.3 mm Origin 0.3 mm
Nominal 1.186 1.176 1.212 1.198
Maximum 1.204 1.211 1.234 1.234
Minimum 1.176 1.157 1.200 1.178
Uncertainties in all values are smaller than 0.2% (1 sd)
Table 4.4: kfclin,fmsrQclin,Qmsr determined for the three geometries by ﬁxing the origin
according to the manual and with the origin displaced 0.3 mm along the
longitudinal axis where the maximum reading from the ionization chamber
was found for the nominal geometry
Geometry
Field size (cm)
10 2 1 0.5 0.45
Nominal 1 0.835 0.640 0.324 0.280
Maximum 0.999 0.834 0.635 0.315 0.271
Minimum 1.001 0.835 0.642 0.330 0.284
Uncertainties in all values are smaller than 0.15% (1 sd)
Table 4.5: Mean absorbed dose in the air cavity for the three geometries
deﬁned for PTW-31016 at 10 MV FFF. Values normalized to the 10 cm
square ﬁeld for the nominal geometry
manual, while the other set is for 0.3 mm in the longitudinal direction of the
stem.
Results presented in Table 4.4 show that inaccuracies in the jaw set-
up from the LINAC have a greater inﬂuence on the correction factor than
the 0.3 mm set-up. Diﬀerences in the correction factor due to geometrical
inaccuracies during the manufacturing process should also be pointed out.
The deposited energy in the air cavity normalized to the 10 cm square
ﬁeld for the nominal geometry is presented in Table 4.5. In order to study the
eﬀect of volume diﬀerences on the mean absorbed dose, diﬀerences between
nominal, maximum and minimum from the average for each ﬁeld size were
calculated. These values are presented in Table 4.6.
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Geometry
Field size (cm)
10 2 1 0.5 0.45
Nominal 0.0 % 0.0 % 0.1 % 0.4 % 0.4 %
Maximum -0.1 % -0.1 % -0.6 % -2.6 % -2.6 %
Minimum 0.1 % 0.1 % 0.5 % 2.1 % 2.3 %
Table 4.6: Diﬀerences between deposited energy in the air cavity between
nominal, maximum and minimum from the average for each ﬁeld size
In Figure 4.3 kfclin,fmsrQclin,Qmsr factors determined for the three geometries for
square ﬁelds up to 2 cm side length are presented. In order to be in line
with experimental procedures, the position that maximizes the reading was
considered, in other words, the position that minimizes the correction factor.
In Tables 4.5 and 4.6 no diﬀerences, within uncertainties, can be observed
in the mean absorbed dose in the air cavity of the ionization chamber for ﬁeld
sizes equal to or above 2 cm for the three deﬁned geometries. These results
agree with what was observed in the previous section for diﬀerent energies
in reference conditions. For ﬁeld sizes larger than 2 cm, the eﬀect on the
mean absorbed dose in the air cavity due to the geometry of a particular
PTW-31016 is negligible. The correction factor for a 2-cm ﬁeld in isocentric
conditions at 10 cm depth is 1.006 independently of the geometries deﬁned
(Figure 4.3).
Below 2 cm, the mean absorbed dose in the air cavity varies for the three
geometries, indicating that the geometry of each user chamber will aﬀect its
correction factor. The largest cavity (maximum geometry) collects a lower
mean dose and consequently will need a higher correction factor. On the
other hand, the mean dose in the minimum geometry is higher and therefore
the correction factor is smaller than the nominal geometry.
The results indicate that the main reason for having correction factors
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Figure 4.3: MC simulation of kfclin,fmsrQclin,Qmsr for the three geometries deﬁned for
PTW-31016 model for square ﬁelds up to 2 cm side length determined at 10
MV FFF
larger than 1 in ionization chambers is the volume eﬀect, which represents
a limitation that aﬀects square ﬁeld sizes up to 2 cm. In addition, in square
ﬁeld sizes up to 1 cm the correction factor for the PTW-31016 will also be
aﬀected by the particular user chamber, since geometrical variations during
the manufacturing process aﬀect the correction factor.
As observed in Figure 4.3, the correction factor increases from 1.8% (min-
imum geometry - smallest cavity) to 2.5% (maximum geometry - largest ca-
vity) when the ﬁeld size is diminished 0.5 mm. As discussed previously, the
maximum geometry will be greater aﬀected by diﬀerences in the ﬁeld size.
To summarize, the kfclin,fmsrQclin,Qmsr correction factors with appropriate un-
certainties proposed for PTW-31016 considering detector set-up, diﬀerences
between ionization chambers of the same model and tolerances in the ﬁeld
size deﬁnition are presented in Table 4.7. Correction factor uncertainty for
the 0.5 ﬁeld size was estimated by considering the uncertainties separately
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Nominal ﬁeld size (cm)
0.5 1 2
kfclin,fmsrQclin,Qmsr 1.17 ±2.8% 1.054 ±0.6% 1.006 ±0.2%
Table 4.7: kfclin,fmsrQclin,Qmsr correction factors for PTW-31016. Assigned uncer-
tainty considering detector set-up, chamber-to-chamber diﬀerences and ﬁeld
size tolerance (coverage factor, k=1)
for the three eﬀects (Values obtained from Table 4.4). Combined uncertain-
ties were obtained by geometric addition of uncertainties (1.5% corresponds
to the geometrical tolerances of the chamber, 0.8% to the set-up position
and 2.2 % to the LINAC jaw set-up).
4.4 Conclusions
The eﬀect that geometrical tolerances during the manufacturing process have
on coeﬃcients and factors related to absorbed dose determination in reference
conditions have been analyzed.
Diﬀerences in the air cavity volume between PTW-31016 chambers of the
same model can reach 23%. These diﬀerences, in reference conditions, will
mainly aﬀect the ND,w,Qo. The diﬀerences in chamber-to-chamber kQ,Qo
due to diﬀerences in the manufacturing process for the three models ana-
lyzed were estimated to be below 0.5%. The variation in wall thickness was
suggested as the main cause of these diﬀerences.
The inﬂuence that the particular geometry of an ionization chamber has
on the kfclin,fmsrQclin,Qmsr factors was determined for the smallest chamber analyzed,
PTW-31016 (0.016 cm3). According to the results presented, a 2.8% un-
certainty should be assigned to the kfclin,fmsrQclin,Qmsr factor for the 0.5 cm square
ﬁeld. This uncertainty would be reduced to 0.6% for a 1 cm square ﬁeld
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size. Finally, it is shown that diﬀerences in kfclin,fmsrQclin,Qmsr between PTW-31016
chambers for a 2 cm square ﬁeld are negligible.

Chapter 5
Small ﬁeld output factors for
TrueBeam FFF beams. Results
and discussion
The results presented have been obtained following the methodology detailed
in section 3.2. MC simulation details can be found in section 2.5.
5.1 Preliminary veriﬁcation. Percentage depth-dose
and oﬀ-axis ratios
Figure 5.1 shows PDDs obtained for 1 and 10 cm square ﬁelds irradiated with
6 MV FFF and 10 MV FFF beams using four detectors. MC simulation re-
sults are included in the graph and are used as reference data for comparison.
The behaviour of the diﬀerent detectors and MC is evaluated by calculating
the gamma function (2 %, 2 mm) and is shown on the right Y-axis of the
graph. Good agreement is found among RK, PTW-31016, Edge detector
and MC simulation for both energies. The particular response of the Scan-
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ditronix shielded diode (PFD) did not agree well with the other detectors
and MC, which has also been previously reported by other researchers [98].
The values of TPR20,10 were found to have diﬀerences lower than 1.2%
for the four energies and agree with previously published data obtained from
averaging results from several LINACs [67, 66].
The OARs for square ﬁelds of side length 1 and 10 cm were compared
with MC simulations for 6 MV FFF and 10 MV FFF. The volumetric eﬀect
of the detectors can be observed on the shoulders (inﬂexion point of the
penumbra) in Figure 5.1. It can be observed that PTW-31016 has better
spatial resolution than RK, due to a smaller diameter. However, the small
volume of the diodes conform a steeper gradient around the inﬂexion points,
as expected.
PDDs and OARs results show good agreement between experimental
and MC simulation. Therefore, it can be concluded that both the the PSFs
provided by Varian and jaws conﬁgurations deﬁned are correct.
5.2 Output ratio determination
Tables 5.1, 5.2, 5.3 and 5.4 show the OR determined using the nine detectors
for ﬁeld sizes ranging from 0.5 cm to 10 cm. OR were determined in isocentric
conditions (SDD = 100 cm) in all cases.
5.3 Field Output Factor determination for square
ﬁelds larger than 2 cm side length
Percentage diﬀerences between the FOF determined by each detector and the
average measured by the ionization chambers for square ﬁelds larger than
2 cm side length are presented in Figure 5.3. For square ﬁelds with a side
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Figure 5.1: Experimental and MC simulated depth-dose curves for 6 MV
FFF (top) and 10 MV FFF (bottom) for ﬁeld sizes of 10 cm and 1 cm.
Gamma (2%, 2 mm) for all detectors is also shown with MC as a reference
on the right Y-axis
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Figure 5.2: Experimental and MC simulated oﬀ-axis ratios for 6 MV FFF
(top) and 10 MV FFF (bottom) for ﬁeld sizes of 10 cm and 1 cm. Gamma
(2%, 2 mm) for all detectors is also shown with MC as a reference on the
right Y-axis
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7
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9
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4
1
0
.7
0
.7
6
4
0
.9
0
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2
8
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0
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1
4
1
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0
.5
0
.4
0
8
3
0
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1
8
0
.9
0
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3
7
0
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0
.3
9
0
2
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0
.4
7
8
3
.0
0
.4
9
5
1
.0
0
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3
4
1
.3
0
.3
8
4
0
.7
0
.4
6
0
2
.0
Table 5.1: Output ratios determined by 9 detectors and the corresponding
calculated uncertainty-u (1sd) for 6 MV. SSD = 95 cm; SDD = 100 cm. (See
section 3.2.2)
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5
1
1
.5
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4
1
0
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3
3
0
.3
0
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1
9
0
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0
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1
5
1
1
0
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5
0
0
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0
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1
7
1
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0
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5
7
2
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0
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2
6
1
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0
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8
4
1
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0
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7
5
0
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0
.7
7
5
0
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0
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5
1
0
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0
.7
6
1
1
0
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0
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7
8
2
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0
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4
2
1
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0
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6
1
0
.7
0
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2
7
2
.2
0
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2
0
3
0
.5
5
2
1
.4
0
.5
5
2
1
.3
0
.4
0
9
1
.4
0
.5
1
7
1
Table 5.2: Output ratios determined by 9 detectors and the corresponding
calculated uncertainty-u (1sd) for 6 MV FFF. SSD = 95 cm; SDD = 100
cm. (See section 3.2.2)
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Table 5.3: Output ratios determined by 9 detectors and the corresponding
calculated uncertainty-u (1sd) for 10 MV. SSD = 90 cm; SDD = 100 cm.
(See section 3.2.2)
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Table 5.4: Output ratios determined by 9 detectors and the corresponding
calculated uncertainty-u (1sd) for 10 MV FFF. SSD = 90 cm; SDD = 100 cm.
(See section 3.2.2)
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length larger than 2.5 cm, FOF were found to be consistent with diﬀerences
lower than 0.8 % between the averaged FOF determined using ionization
chambers and previously published data [67, 66] for the four energies studi-
ed. The eight detectors analyzed showed the same behaviour for FF and
FFF beams. Higher diﬀerences than expected were found when using the
radiochromic ﬁlm EBT-2 for several ﬁeld sizes.
The response of the RK and PTW-31016 was similar for ﬁeld sizes with
a side length larger than 1 cm. However, it was lower than diodes for ﬁeld
sizes up to 2 cm for all energies. The response of the diﬀerent ionization
chambers is related to their cavity volume. Both models present a similar
area on the plane perpendicular to the beam. In the case of the RK model,
it was positioned with the stem parallel to the beam axis, while the PTW-
31016 was placed perpendicular to the beam axis. The same volume eﬀect
could explain the response of the 3.1 mm square TLD. The OR for this
detector are higher for the 1 cm square ﬁeld than for any of the ionization
chambers. However, the dimensions of this detector are too large for the 0.5
cm square ﬁeld.
5.4 Field output factor determination for square
ﬁelds up to 2 cm side length
Table 5.5 shows PTW-31016 FOF derived from the experimental data cor-
rected by kfclin,fmsrQclin,Qmsr from Table 4.7 compared with MC simulated FOFs.
The FOF determined with radiochromic ﬁlms and TLD-700R are also in-
cluded. OR are presented in the case of the Edge detector, although no
speciﬁc correction factors are available for these energies and ﬁeld sizes, they
are included to facilitate comparison. The uncertainty is calculated as men-
CHAPTER 5. SMALL FOF FOR TRUEBEAM 80
Figure 5.3: Percentage diﬀerence in ﬁeld output factors (FOF) for ﬁeld sizes
from 2.5 to 10 cm, with reference to the average FOF determined by the
ionization chambers. Published results acquired under the same conditions
are also presented: Chang et al 2012 for 6 MV and 6 MV FFF and Fogliata
et al 2012 for 10 MV and 10 MV FFF
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tioned in section 3.2.2 except for FOF from PTW-31016 where it is calculated
by combining the uncertainty of OR and kfclin,fmsrQclin,Qmsr .
The diﬀerences between the FOF obtained correcting OR from the PTW-
31016 and the ratios obtained using the TLD-700R, radiochromic ﬁlm and
MC simulation are presented in Figure 5.4. It can be observed that there
is good agreement for TLD with diﬀerences lower than 2.9% except for the
1 cm square for 10 MV FFF. However, the similarity in the response of
MC and radiochromic ﬁlm could suggest some error in the OR determined
using the PTW-31016 in this case. On the other hand, the diﬀerences with
radiochromic ﬁlm are higher, especially for the smallest ﬁeld size.
Figure 5.4: TLD-700R, radiochromic ﬁlm and MC diﬀerences on FOF com-
pared with corrected values obtained with PTW-31016
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Field size length (cm)
2 1 0.5 0.49 0.45
FOF u (%) FOF u (%) FOF u (%) FOF u (%) FOF u (%)
6 MV (SSD = 95 cm; 5 cm depth)
MC 0.840 1.5 0.720 1.5 0.453 1.5 0.453 1.3 0.296 1.4
PTW-
31016
0.852 0.3 0.728 2 0.459 3.6
TLD-700R 0.825 1.0 0.714 1.1 0.460 2.0
Rad. Film 0.856 1.0 0.720 1.0 0.408 3.0
Edge* 0.848 0.1 0.764 0.9 0.534 1.2
6 MV FFF (SSD = 95 cm; 5 cm depth)
MC 0.854 1.3 0.780 1.3 0.549 0.9 0.472 1.2 0.439 1.1
PTW-
31016
0.871 0.3 0.766 2 0.503 3.6
TLD-700R 0.864 1.1 0.761 0.6 0.517 1.1
Rad. Film 0.862 0.6 0.750 0.6 0.478 2.4
Edge* 0.858 0.1 0.775 0.9 0.552 1.3
10 MV (SSD = 90 cm; 10 cm depth)
MC 0.778 1.2 0.594 1.3 0.318 1.3 0.310 1.3 0.280 1.2
PTW-
31016
0.792 0.3 0.609 2 0.347 3.
TLD-700R 0.778 1.1 0.601 1.0 0.339 1.2
Rad. Film 0.777 0.9 0.631 1.8 0.323 2.4
Edge* 0.806 0.1 0.658 1.0 0.415 1.4
10 MV FFF (SSD = 90 cm; 10 cm depth)
MC 0.840 0.1 0.675 0.1 0.382 0.1 0.373 0.6 0.335 0.1
PTW-
31016
0.834 0.3 0.658 2 0.394 3
TLD-700R 0.839 1.5 0.689 1.3 0.392 0.7
Rad. Film 0.851 1.0 0.689 1.0 0.370 1.8
Edge* 0.844 0.1 0.705 0.9 0.459 1.4
Table 5.5: FOF determined by MC simulation, PTW-31016 obtained by
applying the correction factors, TLD-700R and Radiochromic ﬁlm for the
four energies analyzed. *OR (ratios non-corrected) obtained using the Edge
detector are also included
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5.5 Geometric Inaccuracies
Detector set-up
The inﬂuence of the PTW-31016 set-up was studied during the determination
of kfclin,fmsrQclin,Qmsr by MC simulation and has already been presented in Table 4.4.
The analysis performed for the FFF energies using a 1 mm x 1 mm
x 2 mm voxel matrix deﬁned around the geometric centre for the 0.5 cm
square ﬁeld size shows that diﬀerences of 1 mm around the centre result in
diﬀerences of up to 6.5% in the output factor for all energies studied. These
diﬀerences are reduced to 1% for the 1 cm square ﬁeld size.
Jaw set-up
As was explained in section 3.2.5, 0.45 and 0.49 cm square ﬁelds were deﬁned
for all energies to study the eﬀect of jaw tolerances on FOF determination by
MC simulation. The eﬀect of the accuracy of the jaws is shown in Table 5.5
where a 0.5 mm change in the 0.5 cm square ﬁeld can lead to large diﬀerences
in the ﬁeld output factor.
Measurements were repeated using the TLD-700R and the Edge detector
in a second TrueBeam from ECC. Figure 5.5 shows the diﬀerences between
the output ratios for both LINACs. These diﬀerences are consistent with
MC results given the uncertainty of the 0.5 cm square ﬁeld. Consistency
is reinforced by the fact that at the four energies, the diﬀerences in the
LINACs show a similar value and the same direction. The comparison also
shows better reproducibility of the Edge detector compared with the TLDs.
TLDs present a higher variability which is partially associated with set-up
diﬃculties due to the lack of an immediate read-out of these detectors.
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Figure 5.5: Output reading diﬀerences between two LINACs. Outputs were
determined using the Edge detector and the TLD-700R under isocentric
conditions: 5 cm depth for 6 MV and 6 MV FFF and 10 cm depth for 10
MV and 10 MV FFF
5.6 Analysis and discussion
5.6.1 Detector Response
The nine detectors analyzed showed the same behaviour for FF and FFF
beams, even for small ﬁelds, which had also been noted recently by Lechner et
al [103]. Table 5.5 shows good agreement (diﬀerences lower than 5%) between
corrected PTW-31016 FOF and TLD-700R. Radiochromic ﬁlm showed a
good response in square ﬁelds larger than 2 cm and a better response than
the ionization chambers for smaller ﬁelds. The electronic and mass density of
this detector, which is close to water, combined with dose rate independence,
low energy dependence and high resolution give it a potential advantage
over other detectors. However, custom calibration must be performed and
it must be compared with other detectors. At the same time, Figure 5.4
shows a higher dispersion in the diﬀerences compared with FOF obtained
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using PTW-31016.
The largest OR values for the smallest ﬁeld sizes were found using the
diodes. Small diﬀerences between the shielded and unshielded diodes from
Scanditronix were observed. The Edge detector had the largest OR for the
smaller ﬁeld sizes. Several works show that for small ﬁeld sizes this type
of detector, and diodes in general, need correction factors smaller than 1
[98, 99]. Francescon et al [94, 95] report an overestimation of the Edge
detector for nominal 6 MV (FF and FFF) beams from 5 to 8% for 0.5 cm
ﬁeld size. In our case the correction factor seems to be larger. However, the
uncertainty assigned to the ﬁnal FOF determined with PTW-31016 does not
allow a better estimate of the Edge correction factors for the 0.5 cm ﬁeld
size. In Table 5.6 the kfclin,fmsrQclin,Qmsr obtained from our measurements for the
Edge detector are shown. These ratios are derived from the corrected values
using PTW-31016. The uncertainty is derived from the combination of OR
with the Edge detector and the FOF uncertainties using PTW-31016. Small
diﬀerences in kfclin,fmsrQclin,Qmsr between ﬂattened and unﬂattened beams were found
for higher energies.
Field size
(mm)
6 MV 6 MV FFF 10 MV 10 MV FFF
5 0.86 3.2% 0.91 3.3% 0.84 3.3% 0.86 3.3%
10 0.95 2.2% 0.99 2% 0.93 1.7% 0.93 1.9%
20 1.005 0.7% 1.015 0.7% 0.982 0.8% 0.988 0.8%
Square ﬁelds. SDD =100 cm. Depth = 5 cm for 6 MV FF and FFF and 10 cm for 10 MV FF and FFF
Table 5.6: kfclin,fmsrQclin,Qmsr for the Edge detector derived from FOF determined
with the PTW-31016. (1 sd)
A new work presented by Tanny [123] recently appeared (September,
2015) based on experimental measurements, proposing kfclin,fmsrQclin,Qmsr for an
Edge detector for Truebeam beams. However, no direct comparison can be
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done due to diﬀerences in SSD and also ﬁeld sizes since ﬁelds are deﬁned by
cones. Values proposed by Tanny are presented in Table 5.7. As Francescon
[90] pointed out, kfclin,fmsrQclin,Qmsr depends not only on the ﬁeld size, but also on
the depth where they are determined. However their dependence on larger
ﬁeld sizes is lower. Therefore, the results presented in Tables 5.6 and 5.7
are in agreement (considering the uncertainties) for ﬁeld sizes of 1 cm and
larger.
Field size (mm) 6 MV 6 MV FFF 10 MV FFF
6 0.936 0.949 0.901
8 0.946 0.963 0.929
10 0.957 0.977 0.944
20 1.001 1.006 0.983
Circular ﬁelds. SDD =100 cm. Depth = 10 cm
Table 5.7: kfclin,fmsrQclin,Qmsr for Edge detector proposed by Tanny for a TrueBeam.
Field sizes deﬁned by cones
5.6.2 Geometrical inaccuracies
The FOF results obtained by MC simulation for the smallest ﬁeld size, 0.5 cm
square, did not agree with the experimental data (Table 5.5). Gete et al [102]
also observed such discrepancies for 6 MV FFF for 1.0 cm square ﬁeld size.
However, the 2 mm x 2 mm x 10 mm voxel size used in their case may explain
these diﬀerences.
Jaw position accuracy has a great inﬂuence on the output factor for
smaller ﬁeld sizes due to partial occlusion of the target. This makes it diﬃ-
cult to use MC methods to determine the ﬁeld output factor of a particular
LINAC because, even with high resolution in the simulation, it is impossible
to know the true jaw position with the appropriate accuracy. Diﬀerences in
ﬁeld size determination using radiochromic ﬁlm were found to be approxi-
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mately 0.2 mm. Therefore, a 4.9 mm ﬁeld was also simulated to study what
the inﬂuence of 0.1 mm on the ﬁnal output was.
The standard proposal to determine FOF with detectors that need a
correction factor is to apply appropriate kfclin,fmsrQclin,Qmsr either obtained experi-
mentally or by MC, to the detector readings. However, the inﬂuence of the
jaws and detector set-up on the correction factors has only recently been
reported for a ﬁeld size error of 1 mm for ﬂattened beams [91]. In Chapter 4,
we investigated a ﬁeld size uncertainty of 0.5 mm so a MC simulation of
the PTW-31016 was carried out for all energies for 0.45 and 0.5 cm square
ﬁelds. Jaw inaccuracies were found to have a greater eﬀect on FOF than
set-up detector inaccuracies for the smallest ﬁeld size, which agrees with the
ﬁndings of Charles et al for FF beams [91].
5.6.3 Correction factors
The PTW-31016 chamber correction factors, kfclin,fmsrQclin,Qmsr , calculated by MC
for a 10 MV unﬂattened Truebeam beam in nominal square ﬁelds side length
of 2.0 cm, 1.0 cm and 0.5 cm (Table 4.7) were used for the four energies.
FOF obtained using PTW31016 agree with experimental FOF measured
with TLDs and with values obtained by MC. Diﬀerences with TLDs are
lower than 3.2% except for the 1 cm square ﬁeld for 10 MV FFF discussed
previously. Diﬀerences with MC simulation are lower than 2.3% except for
the same ﬁeld and energy than TLDs (1 cm; 10 MV FFF) and also for
the 0.5 cm ﬁeld size for 6MV FFF (9.4% diﬀerence). This discrepancy can
be explained by the uncertainty in the ﬁeld size due to the LINAC jaw
inaccuracy. Thus, agreement between the discussed results also shows low
energy dependance for kfclin,fmsrQclin,Qmsr for all the energies studied.
The simulation of jaw set-up showed large diﬀerences in the output fac-
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tor for the 0.5 cm square ﬁeld. These were greatest for 6 MV FFF, where
0.1 mm represents a diﬀerence of approximately 15% in the output factor.
This eﬀect was checked by comparing two Truebeam LINACs from two diﬀe-
rent institutions. The strong similarity between all parameters in the two
TrueBeams does not apply to the smaller ﬁeld sizes. A diﬀerence of approxi-
mately 13% was found for FOF between both LINACs for 6 MV and 0.5 cm
ﬁeld size (Figure 5.5).
It is our recommendation that MC simulated results and measurements
should not be merged for determining correction factors for ﬁeld sizes below
1 cm, where jaw accuracy is relevant. Correction factors derived from MC
simulations refer to a speciﬁc ﬁeld size and we have seen that diﬀerences
of 0.5 mm in jaw position can lead to 2.2% diﬀerences in kfclin,fmsrQclin,Qmsr for
PTW-31016 (Chapter 4). However, these changes are much smaller than
the change in the FOF related to manufacturer jaw uncertainty. The ﬁnal
uncertainty of the FOF includes both the experimental uncertainty in the
measurement and the eﬀect of jaw inaccuracies on the correction factor.
The backscatter eﬀect on the ﬁnal output factors has been estimated to
be 1.5% for small ﬁelds by Cranmer-Sargison et al [111]. Other authors have
found good agreement without considering backscatter [102]. However, due
to the ﬁnal uncertainty in our results no ﬁrm conclusions about backscatter
can be made.
In a recent work presented by Benmakhlouf et al [124] correction factors
for PTW-31016 in a 6 MV Varian beam are proposed. These results cannot
be directly compared since their determination conditions are at SSD of
100 cm and 10 cm depth. Nevertheless, agreement is reasonable for the
kfclin,fmsrQclin,Qmsr correction factor for a 0.5 cm square. 1.147 in their case for a
ﬁeld size of 0.55 cm on the detector plane, while it is 1.176 in our case for
CHAPTER 5. SMALL FOF FOR TRUEBEAM 89
0.5 cm on the detector plane. For the 1 cm square ﬁeld our value is closer
to that proposed by Czarnecki and Zink [96], where the underestimation for
PTW-31016 is expected to be approximately 5%.
5.7 Conclusions
The response of nine detectors has been characterised for both ﬂattened and
unﬂattened beams. In ﬁelds larger than 2 cm x 2 cm the detectors showed
comparable results. However, in smaller ﬁelds the geometry and nature of
the detectors had a signiﬁcant impact on response and this was found to be
the same for both ﬂattened and unﬂattened beams.
The results show that the ionization chambers studied are not suitable
for square ﬁeld sizes below 2 cm, unless correction factors are used. Ra-
diochromic ﬁlm and TLD-700R gave reasonable results without a speciﬁc
correction factor. Radiochromic ﬁlm is a promising detector for small ﬁelds
when relative measurements are performed on ﬂattened or unﬂattened ﬁelds.
However, due to the large variability in their response, it is strongly recom-
mended that it is not used as a single detector, but is compared with the
response of other types of detector. Despite their depth resolution (6 mm),
TLD-700R are suitable for the ﬁeld sizes studied. However, set-up is critical,
because of the lack of an immediate read-out, their use is not very practical
for systematic measurements.
Comparing our results with previously published studies there are negli-
gible diﬀerences in the main parameters for ﬁeld sizes larger than 2 cm side
length. This should help new users gain conﬁdence when their measured
parameters agree with those published.
The results show the need to perform machine-speciﬁc measurements for
ﬁelds below 1.5 cm, and veriﬁcation after jaw calibration. The proposed
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PTW-31016 correction factors in Chapter 4 have been applied to calculate
FOF at the four energies studied (6 MV and 10 MV FF and FFF) and show
the low dependence that these factors exhibit for this ionization chamber
model.
Chapter 6
Contributions to SABR
treatments. Results and
discussion
The results presented have been obtained following the methodology detailed
in section 3.3.
6.1 Set-up and initial veriﬁcations
This section explores the eﬀect that the level of modulation has on ﬁnal dose
distributions in lung SABR treatments and the inﬂuence that the number
of cycles has on the borders of the ﬁelds. Set-up proposal for lung SABR
treatments is also included.
6.1.1 The eﬀect of low modulated plans
Figure 6.1 shows the comparison between irradiated ﬁlms and predicted dose
distributions in TPS for both initial and low modulated plans for the ﬁrst 6
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patients (See section 3.3.1). The percentage of points with γ(3%, 3mm) > 1
is presented.
Figure 6.1: Percentage of points with γ(3%, 3mm) > 1 for two diﬀerent
levels of modulation for 6 patients. In all cases white represents the initial
modulation while grey shows a plan for the same patient and localization
with a lower modulation. Comparison between static and dynamic condi-
tions is presented in vertical bars. Triangles represent comparison between
TPS dose distributions and measurements on the Quasar phantom in static
conditions. Squares show the comparison between TPS and measurements
performed in dynamic mode of 12 bpm and 1 cm peak to peak
SABR protocols accept maximum doses in PTV as high as 140% of the
prescription dose, this means that there is no need for a high modulation. On
the other hand, tests performed on 10 patients showed that it was not pos-
sible to achieve all dosimetric constraints for all patients without minimum
modulation when coplanar arcs are used.
The vertical bars from Figure 6.1 show that the diminution in modulation
has an eﬀect on the ﬁnal dose distribution compared with static conditions.
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In addition, in all cases the static absorbed dose distribution of the 12 plans
(triangles) was acceptable when compared with the absorbed dose distri-
bution planned with the TPS. This means that the TPS is properly tuned
and the modulation is not excessive in any case in static conditions. This
analysis is proposed to be used as a routine method for motion veriﬁcations,
particularly when hypo-fractionated treatments are considered.
Higher diﬀerences between static-TPS plans (triangles) than the dynamic
and TPS (squares) were found for patients 1 and 6. This may be due to an
eﬀect of compensation at some points between the predicted and delivered
doses, together with the uncertainty in the radiochromic ﬁlm.
Several studies were summarised in the Introduction which analyze the
interplay eﬀect. Most of the studies showed a decrease in the ﬁnal eﬀect
when 30 fractions are delivered. However, there is no general consensus in
the scientiﬁc community on the inﬂuence of intra-fraction movement and
modulation of the plan when a small number of fractions is delivered. It
could be argued that analysis of the interplay eﬀect is only performed in one
fraction instead of 3 or 5 fractions which the real treatment would have and
consequently a decrease of this eﬀect should be expected. It was decided not
to assume any statistical consideration due to the small number of fractions
and be more restrictive in the deﬁnition of a valid plan, accepting a plan
only when the interplay eﬀects fulﬁll the gamma criteria described for each
fraction.
1
1The set-up proposal consisted of 4 arcs 200°-220° long (two arcs for 10 MV FFF)
and the veriﬁcation method proposed, based on the comparison of two irradiations (static
and dynamic) on the Quasar phantom were presented at the 2nd Annual UPMC Beacon
Hospital and UPMC International SRS/SBRT Symposium in Dublin, and it was awarded
1st prize in the Young Investigator's Award in 2013.
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6.1.2 Number of breathing cycles included in each arc
The maximum dose diﬀerence between the dose distribution for n periods and
n periods and a half is shown in Figure 6.2. The distribution was derived from
the convolution of a static proﬁle with a weighted function that represents the
time that the volume is in each position when sinusoidal motion of the volume
is considered. A minimum of 8 periods must be included to have a maximum
diﬀerence lower than 2% on the dose distribution for the three energies. The
number of cycles needed is not dependent on the type of radiation beam
(energy and/or ﬂattening ﬁlter). It is important to notice that this eﬀect is
independent of the modulation and will also aﬀect conformed beams/arcs.
Figure 6.2: Maximum dose diﬀerence at any point of the dose distribution,
between static proﬁles and proﬁles irradiated for n periods and a half as a
function of the n periods
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6.2 PUMA, a method to evaluate the interplay ef-
fect in lung SABR treatments irradiated with
VMAT
6.2.1 Analysis and discussion
In the preliminary investigations low modulated versions of plans 1 to 6,
were created (plans presented in section 6.1.1). Table 6.1 shows the ALPO
for each plan and the results obtained by PUMA compared with those ob-
tained by ﬁlm irradiation inserted within the QUASAR phantom. The ob-
servation that lower modulation resulted in a higher percentage of points
passing PUMA and radiochromic ﬁlm analysis meant that only low modu-
lation plans were considered. Subsequently, a further 6 patients, with low
modulated plans were included in the analysis (Plans 13 to 18).
To study the suitability of PUMA for verifying FFF plans, ﬁve of the
patients in the study were planned using 10 MV FFF. Figure 6.3 presents
the results of the comparison between PUMA and the QUASAR phantom
for the 23 plans proposed in the study.
ALPO is a statistical parameter that can be used to compare diﬀerent
modulation levels for the same volume, but cannot be used directly to predict
the interplay eﬀect, as is suggested by the results included in Table 6.1.
Both PUMA and ﬁlm have been shown to be sensitive to diﬀerent levels
of modulation. However, PUMA does not require accelerator time and can
signiﬁcantly reduce the total veriﬁcation time. ALPO can be used to compare
diﬀerent levels of modulation, however, it is aﬀected by tumour volume and
is diﬃcult to use to assess the interplay eﬀect.
The PUMA method investigates the interplay eﬀect by emulating pe-
riodic tumour motion. Although the sine and cosine waveforms used are
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Patient Plan number ALPO (cm) PUMA*
Quasar +
Rad. Film*
1 1 1.96 4.9 % 4.3 %
7 3.42 0.0 % 2.0 %
2 2 2.04 9.2 % 7.1 %
8 2.71 3.2 % 2.5 %
3 3 2.74 11.7 % 3.7 %
9 3.10 0.4 % 0.2 %
4 4 1.92 2.1 % 3.6 %
10 3.56 0.0 % 1.4 %
5 5 1.89 1.2 % 3.3 %
11 2.39 0.0 % 0.0 %
6 6 1.38 17.8 % 8.1 %
12 2.35 4.5 % 0.0 %
*Percentage of points failing the acceptance criteria
Table 6.1: Interplay eﬀect analysis performed on 6 patients for two diﬀerent
levels of modulation using PUMA and the Quasar phantom. Plans 1 to 6
represent the initial modulation and plans 7 to 12 have lower modulation.
The average leaf pair aperture (ALPO) is also scored
idealistic, they cover situations where irradiation begins with the tumour at
the centre (sine) and at the edge (cosine) of the ﬁeld. The method could,
however, be easily adapted to any breathing waveform or tumour motion.
Both methods agree on the suitability of the plans with the exception of
plan 3. The PUMA method predicts an unacceptable interplay eﬀect, which
is not identiﬁed by the ﬁlm. This may be due to the fact that PUMA analyses
the whole ITV instead of only the sagittal plane in the case of ﬁlm. These
preliminary results indicate that PUMA may be an eﬀective alternative to
ﬁlm-based veriﬁcation. At present, it is being used to prevent plans failing
QUASAR ﬁlm veriﬁcation. However, in the future, it could be used as an
exclusive method for veriﬁcation. In addition, the same method could be
adapted to verify the interplay eﬀect in IMRT lung SABR plans. It is also
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Figure 6.3: Interplay eﬀect analysis. Comparison between PUMA method
and veriﬁcations performed on a Quasar phantom comparing static and dy-
namic dose distributions. For the PUMA method the positive and nega-
tive diﬀerence between the plan with a unique isocentre and the most un-
favourable plan created by applying sine or cosine functions at the position
of the isocentre on the cranio-caudal direction
important to notice that PUMA method can also be used for all energies as
well as with ﬂattened and unﬂattened beams.
6.2.2 PUMA compared with other methods/modulation in-
dices
Modulation indices calculated for the 23 plans are scored in Table 6.2. At
present, there are no published values for the proposed indices to evaluate
the interplay eﬀect. As already mentioned previously, the interplay eﬀect is
a combined eﬀect of modulation and motion. The initial analysis performed
was based on the correlation between the proposed indices and radiochromic
ﬁlm. A statistical analysis of the goodness of ﬁt was done and determined
that there is signiﬁcant correlation (p < 0.0001) between radiochromic ﬁlm
and PUMA, radiochromic ﬁlm and MIt and also between PUMA and MIt.
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According to these results just PUMA and MIt seem to be able to predict
failing plans in a Quasar phantom.
Plan Rad. ﬁlm PUMA MCS MIt AI
1 4.3 4.9 0.19 0.83 5.75
2 7.1 9.2 0.20 0.72 5.31
3 3.7 11.7 0.24 0.66 6.68
4 3.6 2.1 0.18 0.70 8.33
5 3.3 1.2 0.24 0.49 4.28
6 8.1 17.8 0.60 1.04 1.69
7 2 0.0 0.45 0.33 1.86
8 2.5 3.2 0.28 0.45 3.49
9 0.2 0.4 0.31 0.54 4.69
10 1.4 0.0 0.41 0.37 3.50
11 0.0 0.0 0.31 0.44 3.08
12 0.0 4.5 0.32 0.44 2.81
13 0.3 0.0 0.42 0.38 2.24
14 3.0 2.0 0.43 0.55 5.11
15 0.2 0.0 0.45 0.38 3.68
16 2.9 0.5 0.34 0.60 3.80
17 2.5 0.5 0.30 0.52 4.21
18 1.6 0.0 0.48 0.37 3.29
19 1.5 0.0 0.43 0.41 2.02
20 15.1 9.0 0.24 0.79 4.31
21 1.7 0.8 0.29 0.48 3.54
22 0.0 0.0 0.41 0.42 2.22
23 3.2 0.0 0.35 0.43 2.76
MCS - Proposed by McNiven 2010.[116]
MIt - Based on Park at 2014. [117]
AI - Introduced by Du in 2014. [118]
Table 6.2: Modulation indices proposed in the literature calculated for 23
plans, compared with percentage of points with γ(3%, 3mm) > 1 on ra-
diochromic ﬁlm and percentage of points that fails the PUMA acceptance
criterion. 4 arcs and 6 MV FF were used in plans 1 to 17 and two arcs 10
MV FFF for the last ﬁve plans
From analysis of Table 6.2, a value of 0.6 for the MIt index is proposed
as the upper limit when evaluating the suitability of a plan to the interplay
eﬀect. This value was selected in order to minimize the number of false
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negative plans in the analysis. A positive plan is considered to be a plan
suitable for treatment, while a negative plan is an unsuitable plan due to the
interplay eﬀect. Table 6.3 shows statistical parameters for PUMA and MIt.
Both methods have the same speciﬁcity so all failing plans were detected.
However PUMA, as discussed previously, has only a single false positive in
comparison with the 3 false positives for MIt.
The low number of plans analyzed (23) until now must be considered
before using the PUMA or MIt index as exclusive veriﬁcation methods for
the evaluation of the interplay eﬀect.
Finally, it should be mentioned that the MIt analysis is much faster than
PUMA and, of course, the Quasar phantom since it only requires the export
of the treatment plan in DICOM format and run the software which takes less
than one minute. The evaluation of a greater number of plans will contribute
to setting 0.6 as the benchmark for MIt analysis or slightly modify it.
Positive
Predictive
Value
(PPV)
Negative
Predictive
Value
(NPV)
Sensitivity Speciﬁcity Accuracy
PUMA 100 % 75% 95% 100% 95.7%
MIt 100 % 50% 85% 100% 87.0%
Table 6.3: Statistical analysis of PUMA and MIt
6.3 Conclusions
Low modulated coplanar arcs, properly veriﬁed, can be used in lung SABR.
The MU delivered per Gy and ALPO are indicators of the modulation of a
plan, but they are not suitable for evaluating the interplay eﬀect.
PUMA predicts the eﬀects of the volume motion and can be used to
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verify the interplay eﬀect. In the future, PUMA could be used as an exclusive
method for motion veriﬁcation since it can be used for all energies as well as
with FF and FFF beams.
Most of the modulation indices proposed in the literature are related
to the robustness and modulation of a plan. However, none of them has
been conceived to appropriately predict the interplay eﬀect in lung SABR.
MIt proposed by Park [117] has been found to be the only published index
capable of detecting failing plans. MIt and PUMA have the same speciﬁcity
since both detected all of the failing plans. However, PUMA has a greater
accuracy and sensitivity. According to the results presented, 0.6 is proposed
as the benchmark for the MIt index to evaluate the interplay eﬀect in lung
SABR.
Chapter 7
Final conclusions
This thesis has contributed to improve our knowledge of some of the present
challenges in radiotherapy.
1. An upper limit for the inﬂuence that diﬀerences between chambers
of the same model have on their kQ,Qohas been ﬁxed for three of the
most common ionization chambers used in radiotherapy, PTW-30013,
PTW-31010 and PTW-31016. In addition, the manufacturing toleran-
ces in the wall thickness of chambers of the same model have been
identiﬁed as the main source of kQ,Qo variation. This sets the minimum
uncertainty (0.5%) that should be assigned to any kQ,Qo used from
protocols or the literature in general.
2. kfclin,fmsrQclin,Qmsr correction factors have been determined for the PTW-31016
ionization chamber model for unﬂattened beams from a Truebeam.
The eﬀect of the particularities of each individual chamber has been
studied and their inﬂuence on ﬁnal values has been found to be 0.6%
for ﬁeld sizes greater than or equal to one and 2.8% for 0.5 cm square
ﬁeld.
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3. Output ratios for 6 MV and 10 MV ﬂattened and unﬂattened beams
from a Truebeam have been measured using nine detectors in the range
0.5 to 10 cm square side length. FOF has been determined experimen-
tally and using MC. The FOF determined with the eight detectors
analyzed for ﬁeld sizes larger than 2 cm square show values within 2%
between the average of several ionization chambers when compared
with results from the literature.
4. FOF for 6 MV and 10 MV ﬂattened and unﬂattened beams from a
Truebeam were determined using PENELOPE MC code in the range
0.5 to 2 cm. It has been shown that below 2 cm, tested ionization
chambers and diodes require correction factors.
5. FOF measured with TLDs and with PTW-31016 by applying the pro-
posed kfclin,fmsrQclin,Qmsr correction factors agreed to within 5% even for the
smallest ﬁeld size (0.5 cm).
6. Low energy dependence of kfclin,fmsrQclin,Qmsr correction factors was veriﬁed
for PTW-31016.
7. The Edge detector requires correction factors lower than 1 for ﬁeld
sizes below 2 cm. A range of values for the four energies analyzed and
ﬁeld sizes up to 2 cm have been proposed.
8. FOF values for the 0.5 cm square side length are machine speciﬁc,
mainly due to the eﬀect of LINAC jaw uncertainties in this range.
Thus, MC calculation of FOF is not suitable in this case. Diﬀerences
of up to 13% between FOF determined in two TrueBeams were found
for 6 MV FFF.
9. A low modulated VMAT class solution has been proposed to deliver
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both fast and accurate SABR treatments.
10. A minimum of 8 respiratory cycles should be included for a beam/arc
during irradiation to diminish the eﬀect of the number of breathing
cycles independently of the modulation of the plan.
11. PUMA, a method to evaluate the interplay eﬀect, has been developed
and presents a higher speciﬁcity than any other index/method in the
literature.
12. The MIt index was found to have a lower accuracy than PUMA. At
present the MIt index is the only proposed index in the literature that
can accurately predict the interplay eﬀect in lung SABR.
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